<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">D4F8TyNxvXBYNXKBpZxwZTC</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S0066-782X2023000300301</article-id>
      <article-id pub-id-type="other">00301</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20220135</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigo Original</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Impacto da COVID-19 nos Programas de Reabilita&#231;&#227;o Cardiovascular no Brasil: Um Estudo Transversal Baseado em uma Pesquisa Online</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-7651-699X</contrib-id>
          <name>
            <surname>Jardim</surname>
            <given-names>Iara de Sousa Cez&#225;rio</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados e An&#225;lise estat&#237;stica</role>
          <role>Reda&#231;&#227;o do manuscrito</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-3688-2108</contrib-id>
          <name>
            <surname>Milani</surname>
            <given-names>Mauricio</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>Reda&#231;&#227;o do manuscrito</role>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castro</surname>
            <given-names>Isac</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados e An&#225;lise estat&#237;stica</role>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hansen</surname>
            <given-names>Dominique</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-2476-7981</contrib-id>
          <name>
            <surname>Karsten</surname>
            <given-names>Marlus</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cahalin</surname>
            <given-names>Lawrence Patrick</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
          <xref ref-type="aff" rid="aff7">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cipriano</surname>
            <given-names>Graziella Fran&#231;a Bernardelli</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-6323-7003</contrib-id>
          <name>
            <surname>Cipriano</surname>
            <given-names>Gerson</given-names>
            <suffix>Jr</suffix>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante</role>
          <role>Obten&#231;&#227;o de dados</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados e An&#225;lise estat&#237;stica</role>
          <role>Reda&#231;&#227;o do manuscrito</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgdiv1">PPGCR</institution>
        <institution content-type="orgname">Universidade de Bras&#237;lia</institution>
        <addr-line>
          <named-content content-type="city">Bras&#237;lia</named-content>
          <named-content content-type="state">DF</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Programa de P&#243;s Gradua&#231;&#227;o em Ci&#234;ncias da Reabilita&#231;&#227;o (PPGCR), Universidade de Bras&#237;lia (UNB), Bras&#237;lia, DF &#8211; Brasil</institution>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution content-type="orgname">Fitcordis</institution>
        <addr-line>
          <named-content content-type="city">Bras&#237;lia</named-content>
          <named-content content-type="state">DF</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Fitcordis, Bras&#237;lia, DF &#8211; Brasil</institution>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution content-type="orgdiv1">PPGCTS</institution>
        <institution content-type="orgname">Universidade de Bras&#237;lia</institution>
        <addr-line>
          <named-content content-type="city">Bras&#237;lia</named-content>
          <named-content content-type="state">DF</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Programa de P&#243;s Gradua&#231;&#227;o em Ci&#234;ncias e Tecnologias em Sa&#250;de (PPGCTS), Universidade de Bras&#237;lia (UNB), Bras&#237;lia, DF &#8211; Brasil</institution>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Universidade de S&#227;o Paulo, S&#227;o Paulo, SP &#8211; Brasil</institution>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <institution content-type="orgname">Hasselt University</institution>
        <addr-line>
          <named-content content-type="city">Hasselt</named-content>
        </addr-line>
        <country country="BE">B&#233;lgica</country>
        <institution content-type="original">Hasselt University, Hasselt &#8211; B&#233;lgica</institution>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <institution content-type="orgdiv1">PPGFT</institution>
        <institution content-type="orgname">Universidade do Estado de Santa Catarina</institution>
        <addr-line>
          <named-content content-type="city">Florian&#243;polis</named-content>
          <named-content content-type="state">SC</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Programa de P&#243;s-gradua&#231;&#227;o em Fisioterapia (PPGFT), Universidade do Estado de Santa Catarina, Florian&#243;polis, SC &#8211; Brasil</institution>
      </aff>
      <aff id="aff7">
        <label>7</label>
        <institution content-type="orgname">Miller School of Medicine</institution>
        <addr-line>
          <named-content content-type="city">Miami</named-content>
          <named-content content-type="state">Fl&#243;rida</named-content>
        </addr-line>
        <country country="US">EUA</country>
        <institution content-type="original">Miller School of Medicine, Miami, Fl&#243;rida &#8211; EUA</institution>
      </aff>
      <author-notes>
        <corresp id="c01"> Correspond&#234;ncia: Iara de Sousa Cez&#225;rio Jardim &#8226; Universidade de Bras&#237;lia &#8211; ci&#234;ncias da reabilita&#231;&#227;o &#8211; Campus Universit&#225;rio, s/n. CEP 70910-900, Centro Metropolitano, Bras&#237;lia, DF &#8211; Brasil E-mail: <email>iaracezario@gmail.com</email> </corresp>
        <fn fn-type="conflict">
          <p>Potencial conflito de interesse</p>
          <p>N&#227;o h&#225; conflito com o presente artigo.</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>10</day>
        <month>03</month>
        <year>2023</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2023</year>
      </pub-date>
      <volume>120</volume>
      <issue>3</issue>
      <elocation-id>e20220135</elocation-id>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>02</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>19</day>
          <month>10</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <title>Resumo</title>
        <sec>
          <title>Fundamento</title>
          <p> A pandemia da COVID-19 teve um impacto sobre os programas de reabilita&#231;&#227;o cardiovasculares (RC) no Brasil.</p>
        </sec>
        <sec>
          <title>Objetivos</title>
          <p> Descrever caracter&#237;sticas dos programas de RC no Brasil, os impactos da primeira onda epidemiol&#243;gica da COVID-19 (primeiros 60 dias) sobre os programas, e apresentar as iniciativas usadas para superar esses impactos.</p>
        </sec>
        <sec>
          <title>M&#233;todos</title>
          <p> Este estudo transversal e retrospectivo usou um question&#225;rio online espec&#237;fico. Os participantes eram coordenadores de programas de RC. As vari&#225;veis foram apresentadas por regi&#227;o geogr&#225;fica do Brasil, como as seguintes categorias: caracter&#237;stica demogr&#225;ficas, cl&#237;nicas e operacionais. O n&#237;vel de signific&#226;ncia estat&#237;stica foi definido em 5%.</p>
        </sec>
        <sec>
          <title>Resultados</title>
          <p> Cinquenta e nove programas de RC atendiam 5349 pacientes, dos quais somente 1817 eram pacientes ap&#243;s eventos cardiovasculares agudos, o que correspondia a 1,99% dos pacientes internados no m&#234;s anterior &#224; pesquisa (n=91.231). O maior impacto foi a suspens&#227;o das atividades presenciais, o que ocorreu de maneira similar em &#225;reas com as taxas mais altas e &#225;reas com as taxas mais baixas de COVID-19 no per&#237;odo. Quarenta e quatro (75%) programas foram interrompidos de forma breve, e tr&#234;s (5%) foram encerrados. Todos os 42 programas que j&#225; utilizavam estrat&#233;gias de reabilita&#231;&#227;o remota notaram aumento substancial nas atividades, baseadas principalmente no uso da m&#237;dia e chamadas por v&#237;deo. Somente tr&#234;s (5%) consideraram seguro atender pacientes durante os primeiros 60 dias.</p>
        </sec>
        <sec>
          <title>Conclus&#245;es</title>
          <p> Houve redu&#231;&#227;o no n&#250;mero de programas de RC devido a pandemia da COVID-19. Atividades de telerreabilita&#231;&#227;o aumentaram durante os primeiros dois meses da pandemia da COVID-19, mas que n&#227;o foi suficiente para superar a redu&#231;&#227;o nas atividades dos programas de RC no Brasil.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="pt">
        <kwd>COVID-19</kwd>
        <kwd>Telerreabilita&#231;&#227;o</kwd>
        <kwd>Reabilita&#231;&#227;o Card&#237;aca, Pesquisa, Inqu&#233;ritos e Question&#225;rios</kwd>
      </kwd-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="6"/>
        <equation-count count="0"/>
        <ref-count count="31"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introdu&#231;&#227;o</title>
      <p>Em mar&#231;o de 2020, uma pandemia mundial foi declarada devido &#224; emerg&#234;ncia da COVID-19 ( <italic>coronavirus disease</italic> 2019).<sup><xref ref-type="bibr" rid="B1">1</xref></sup> N&#227;o havia nenhum medicamento espec&#237;fico ou vacinas regulamentadas para tratar a doen&#231;a causada pelo SARS-CoV-2 durante a primeira metade de 2020.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> Medidas preventivas para reduzir a r&#225;pida dissemina&#231;&#227;o desse v&#237;rus respirat&#243;rio, incluindo distanciamento social, foram ent&#227;o recomendadas em todo o mundo.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> A recomenda&#231;&#227;o de se reduzir o contato f&#237;sico, feita por ag&#234;ncias de sa&#250;de, aumentou as restri&#231;&#245;es no acesso a muitas &#225;reas p&#250;blicas e privadas, incluindo a servi&#231;os de sa&#250;de.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> Esse fen&#244;meno tamb&#233;m ocorreu no Brasil, onde o primeiro caso relatado foi em 25 de fevereiro de 2020, nove semanas ap&#243;s o primeiro caso relatado na China.<sup><xref ref-type="bibr" rid="B5">5</xref></sup> Em Bras&#237;lia, por exemplo, o governo lan&#231;ou o primeiro decreto para o fechamento de v&#225;rios estabelecimentos em 11 de mar&#231;o de 2020 (11&#170; semana epidemiol&#243;gica).<sup><xref ref-type="bibr" rid="B6">6</xref></sup> Tais recomenda&#231;&#245;es continuaram a mudar ao longo do ano, e altera&#231;&#245;es nas restri&#231;&#245;es ainda eram anunciadas nos primeiros meses de 2021.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
      <p>De acordo com publica&#231;&#245;es recentes, condi&#231;&#245;es cr&#244;nicas, incluindo doen&#231;as cardiovasculares e doen&#231;as pulmonares, diabetes mellitus, e hipertens&#227;o, foram associadas a manifesta&#231;&#245;es mais graves da infec&#231;&#227;o por COVID-19 e pior progn&#243;stico.<sup><xref ref-type="bibr" rid="B8">8</xref> , <xref ref-type="bibr" rid="B9">9</xref></sup> Assim, indiv&#237;duos com essas condi&#231;&#245;es foram solicitados a aumentar as medidas de precau&#231;&#227;o e manter os tratamentos cl&#237;nicos e, assim, evitar contamina&#231;&#227;o, descompensa&#231;&#227;o e outras interna&#231;&#245;es.<sup><xref ref-type="bibr" rid="B10">10</xref></sup></p>
      <p>Embora considerada um componente vital no tratamento da insufici&#234;ncia card&#237;aca,<sup><xref ref-type="bibr" rid="B11">11</xref> , <xref ref-type="bibr" rid="B12">12</xref></sup> a disponibilidade e a ades&#227;o &#224; reabilita&#231;&#227;o cardiovascular (RC) tamb&#233;m foram tamb&#233;m foram muito afetadas devido &#224;s novas restri&#231;&#245;es durante a pandemia.<sup><xref ref-type="bibr" rid="B13">13</xref></sup> A RC &#233; composta de componentes chave espec&#237;ficos que t&#234;m como objetivo estimular h&#225;bitos saud&#225;veis, promover um estilo de vida ativo, otimizar condi&#231;&#245;es cl&#237;nicas, e reduzir riscos cardiovasculares,<sup><xref ref-type="bibr" rid="B11">11</xref></sup> corroborando evid&#234;ncias robustas de sua capacidade em prevenir hospitaliza&#231;&#245;es e melhorar a aptid&#227;o cardiorrespirat&#243;ria de maneira custo-efetiva.<sup><xref ref-type="bibr" rid="B14">14</xref> , <xref ref-type="bibr" rid="B15">15</xref></sup></p>
      <p>Este estudo tem como objetivo descrever as caracter&#237;sticas dos Programas de Reabilita&#231;&#227;o Card&#237;aca (PRCs) no Brasil antes e durante a pandemia, verificar o impacto da pandemia da COVID-19 (60 dias ap&#243;s o primeiro caso confirmado da COVID-19 no Brasil), e descrever as principais iniciativas criadas para manter os PRCs face &#224;s restri&#231;&#245;es impostas por autoridades p&#250;blicas.</p>
    </sec>
    <sec sec-type="methods">
      <title>M&#233;todos</title>
      <sec>
        <title>Aprova&#231;&#227;o &#233;tica e delineamento metodol&#243;gico</title>
        <p>Neste estudo retrospectivo, transversal, utilizou-se uma pesquisa <italic>online</italic> desenvolvida por profissionais de RC e pesquisadores. O estudo foi aprovado pelo comit&#234; de &#233;tica (n&#250;mero CAAE 36041220.4.0000.8093). Os participantes assinaram um acordo de confidencialidade descrevendo o prop&#243;sito cient&#237;fico e o anonimato na apresenta&#231;&#227;o de seus dados durante um webinar cient&#237;fico internacional, organizado pelo <italic>International Council of Cardiovascular Prevention and Rehabilitation</italic> .<sup><xref ref-type="bibr" rid="B16">16</xref></sup></p>
      </sec>
      <sec>
        <title>Pesquisa <italic>online</italic></title>
        <p>A pesquisa <italic>online</italic> foi elaborada por dois pesquisadores, para apresentar, pela primeira vez na literatura, dados brasileiros sobre o impacto da COVID-19 na RC.<sup><xref ref-type="bibr" rid="B16">16</xref></sup> Os dados completos coletados foram registrados para posterior avalia&#231;&#227;o ap&#243;s a aprova&#231;&#227;o &#233;tica.</p>
        <p>Um programa gratuito (Google forms, Google LLC, California, Estados Unidos) foi usado para desenvolver quest&#245;es objetivas e subjetivas do question&#225;rio. O question&#225;rio foi distribu&#237;do entre 20 e 30 de abril de 2020 (60 dias ap&#243;s o primeiro caso confirmado de COVID-19 no Brasil). A sequ&#234;ncia das quest&#245;es teve como objetivo prim&#225;rio caracterizar os servi&#231;os de RC antes da pandemia da COVID-19 e, segundo, apresentar adapta&#231;&#245;es potenciais para o novo cen&#225;rio da pandemia. Embora n&#227;o houvesse limite de tempo para os participantes completarem o question&#225;rio, o tempo aproximado para o preenchimento do formul&#225;rio foi de 10 a 15 minutos por participante. Cada p&#225;gina tinha de ser completamente respondida para o total preenchimento do question&#225;rio. A vers&#227;o em portugu&#234;s usada no estudo ainda est&#225; dispon&#237;vel <italic>online</italic> para consulta (https://forms.gle/hWiKojuAz68FpUeD6)</p>
        <p>Os profissionais da RC tamb&#233;m foram solicitados a concordar com os termos de divulga&#231;&#227;o, consentindo com a apresenta&#231;&#227;o an&#244;nima dos dados no <italic>webinar</italic> da ICCPR e publica&#231;&#227;o cient&#237;fica ap&#243;s aprova&#231;&#227;o pelo comit&#234; de &#233;tica.</p>
      </sec>
      <sec>
        <title>Participantes, e crit&#233;rios de inclus&#227;o e exclus&#227;o</title>
        <p>Os participantes do estudo eram coordenadores de PRCs selecionados por amostragem n&#227;o probabil&#237;stica. O <italic>link</italic> para acessar o question&#225;rio <italic>online</italic> foi disponibilizado por redes sociais, e os receptores foram encorajados a enviar o convite a outros profissionais para alcan&#231;ar o maior n&#250;mero poss&#237;vel de profissionais (isto &#233;, estrat&#233;gia &#8220;bola de neve&#8221;).</p>
        <p>Como crit&#233;rios de inclus&#227;o, o PCR tinha que oferecer ao menos um dos oito componentes centrais recomendados na literatura.<sup><xref ref-type="bibr" rid="B11">11</xref></sup> Question&#225;rios em duplicata ou respondidos apenas parcialmente foram exclu&#237;dos do estudo.</p>
      </sec>
      <sec>
        <title>An&#225;lise estat&#237;stica</title>
        <p>O teste de Kolmogorov-Smirnov foi usado para verificar a normalidade da distribui&#231;&#227;o dos dados da amostra. Como os dados n&#227;o apresentaram distribui&#231;&#227;o normal, as vari&#225;veis cont&#237;nuas foram descritas em mediana e intervalo interquartil. Os dados categ&#243;ricos foram apresentados como frequ&#234;ncia absoluta e porcentagens. Os dados foram analisados usando o teste de McNemar, em uma tabela 2x2, considerando: 1) a estrat&#233;gia promoveu mudan&#231;a de comportamento; 2) come&#231;ou a usar estrat&#233;gia ou interrompeu seu uso em dois momentos &#8211; antes e ap&#243;s a pandemia. Os dados categ&#243;ricos foram comparados usando o teste do X<sup>2</sup>. O teste de Kruskal-Wallis foi usado para comparar medianas de dados n&#227;o param&#233;tricos. Usamos um p&lt;0,05 e um erro beta &#8804; 0,2 para signific&#226;ncia estat&#237;stica. As an&#225;lises estat&#237;sticas foram realizadas usando o programa SPSS, vers&#227;o 23.0 para MacOS.</p>
        <p>Um total de 57 PRCs seria necess&#225;rio (76% dos participantes). Esse n&#250;mero foi calculado usando um z-escore de 1,96 e margem de erro de 6%, e considerando um n&#250;mero total estimado de 75 PRCs no Brasil.<sup><xref ref-type="bibr" rid="B17">17</xref></sup> Os c&#225;lculos foram realizados usando o programa StatCatl, EPIinfo, e os question&#225;rios populacionais do CDC ( <italic>Centers for Disease Control and Prevention</italic> ). Para estimar a demanda por PRC no Brasil e por regi&#227;o geogr&#225;fica, consideramos o n&#250;mero de interna&#231;&#245;es por doen&#231;a cardiovascular no m&#234;s anterior &#224; pesquisa &#8211; mar&#231;o de 2020,<sup><xref ref-type="bibr" rid="B18">18</xref></sup> (uma vez que o n&#250;mero de interna&#231;&#245;es foi similar &#224; m&#233;dia de 12 meses anteriores), dividido pelo n&#250;mero de sess&#245;es de RC potencialmente dispon&#237;vel para os pacientes que tiveram um evento cardiovascular agudo recente (&lt;12 semanas).</p>
        <p>Para calcular a taxa m&#233;dia de infec&#231;&#227;o por COVID-19 no m&#234;s de abril de 2020 por regi&#227;o geogr&#225;fica, n&#243;s consideramos o n&#250;mero de casos registrados no sistema nacional de sa&#250;de em 2020,<sup><xref ref-type="bibr" rid="B19">19</xref></sup> dividido pelo n&#250;mero de habitantes registrados pelo Instituto Brasileiro de Geografia e Estat&#237;stica para o mesmo per&#237;odo.<sup><xref ref-type="bibr" rid="B20">20</xref></sup> A raz&#227;o foi expressa por 100 000 habitantes.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Resultados</title>
      <sec>
        <title>Caracter&#237;sticas dos programas de reabilita&#231;&#227;o cardiovascular antes da pandemia da COVID-19</title>
        <p>A taxa de resposta ao nosso question&#225;rio foi de 78,66% do n&#250;mero esperado (61 de 75 programas). Dois programas foram exclu&#237;dos por duplicidade, resultando em 59 question&#225;rios para an&#225;lise.</p>
        <p>As caracter&#237;sticas dos PRCs antes da pandemia da COVID-19 foram categorizadas de acordo com as regi&#245;es geogr&#225;ficas do Brasil &#8211; norte (N), nordeste (NE), centro-oeste (CO), sudeste (SE), e sul (S) ( <xref ref-type="table" rid="t1">Tabela 1</xref> ).</p>
        <p>
          <table-wrap id="t1">
            <label>Tabela 1</label>
            <caption>
              <title>&#8211; Caracter&#237;sticas cl&#237;nicas e demogr&#225;ficas dos programas de reabilita&#231;&#227;o cardiovascular antes do primeiro caso de COVID-19 confirmado no Brasil e interna&#231;&#245;es por doen&#231;as cardiovasculares por regi&#227;o brasileira</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" colspan="2" rowspan="3">Caracter&#237;sticas demogr&#225;ficas</th>
                  <th colspan="5">Regi&#227;o brasileira</th>
                  <th rowspan="3">Total</th>
                  <th rowspan="3">p</th>
                </tr>
                <tr>
                  <th colspan="5">
                    <hr/>
                  </th>
                </tr>
                <tr>
                  <th>Centro-oeste</th>
                  <th>Nordeste</th>
                  <th>Sul</th>
                  <th>Sudeste</th>
                  <th>Norte</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td rowspan="13">Perfil do servi&#231;o oferecido em mediana (IIQ) ou <italic>n (%)</italic></td>
                  <td>Tempo de exist&#234;ncia (meses)</td>
                  <td align="center">77 (42 -131)</td>
                  <td align="center">68 (28 - 96)</td>
                  <td align="center">57 (20 - 229)</td>
                  <td align="center">141 (70 - 238)</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                  <td align="center">0,26</td>
                </tr>
                <tr>
                  <td>N&#250;mero de programas</td>
                  <td align="center">9 (15,25)</td>
                  <td align="center">8 (13,55)</td>
                  <td align="center">12 (20,33)</td>
                  <td align="center">30 (50,84)</td>
                  <td align="center">-</td>
                  <td align="center">59</td>
                  <td align="center">-</td>
                </tr>
                <tr>
                  <td>&#205;ndice de desenvolvimento humano</td>
                  <td align="center">0,757</td>
                  <td align="center">0,663</td>
                  <td align="center">0,754</td>
                  <td align="center">0,766</td>
                  <td align="center">0,667</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                </tr>
                <tr>
                  <td>N&#250;mero de pacientes por m&#234;s (por programa)</td>
                  <td align="center">50 (20 - 50)</td>
                  <td align="center">18 (7 - 65)</td>
                  <td align="center">25 (7 - 115)</td>
                  <td align="center">78 (49 - 180)</td>
                  <td align="center">-</td>
                  <td align="center" rowspan="2">5.349</td>
                  <td align="center" rowspan="2">0,01</td>
                </tr>
                <tr>
                  <td>N&#250;mero de pacientes por m&#234;s</td>
                  <td align="center">428 (8)</td>
                  <td align="center">270 (5,04)</td>
                  <td align="center">985 (18,41)</td>
                  <td align="center">3,711 (69,37)</td>
                  <td align="center">-</td>
                </tr>
                <tr>
                  <td>N&#250;mero de sess&#245;es por m&#234;s (por programa)</td>
                  <td align="center">200 (12 - 280)</td>
                  <td align="center">76 (12 - 220)</td>
                  <td align="center">40 (10 - 132)</td>
                  <td align="center">180 (50 - 400)</td>
                  <td align="center">-</td>
                  <td align="center" rowspan="2">32.449</td>
                  <td align="center" rowspan="2">0,25</td>
                </tr>
                <tr>
                  <td>N&#250;mero de sess&#245;es por m&#234;s</td>
                  <td align="center">3.016 (9,29)</td>
                  <td align="center">1.764 (5,43)</td>
                  <td align="center">5.080 (15,65)</td>
                  <td align="center">22.589 (69,61)</td>
                  <td align="center">-</td>
                </tr>
                <tr>
                  <td>Porcentagem de pacientes em baixo risco* por m&#234;s (por programa)</td>
                  <td align="center">30 (20 - 50)</td>
                  <td align="center">15 (5 - 55)</td>
                  <td align="center">30 (10 - 50)</td>
                  <td align="center">25 (20 - 50)</td>
                  <td align="center">-</td>
                  <td align="center">1.407</td>
                  <td align="center">0,54</td>
                </tr>
                <tr>
                  <td>Porcentagem de pacientes em risco moderado* por m&#234;s (por programa)</td>
                  <td align="center">50 (30 - 60)</td>
                  <td align="center">50 (20 - 65)</td>
                  <td align="center">35 (20 - 50)</td>
                  <td align="center">35(20 - 5)</td>
                  <td align="center">-</td>
                  <td align="center">2.145</td>
                  <td align="center">0,27</td>
                </tr>
                <tr>
                  <td>Porcentagem de pacientes em alto risco* por m&#234;s (por programa)</td>
                  <td align="center">20 (10 - 20)</td>
                  <td align="center">30 (10 - 50)</td>
                  <td align="center">25 (5 - 55)</td>
                  <td align="center">30 (20 - 50)</td>
                  <td align="center">-</td>
                  <td align="center">2.097</td>
                  <td align="center">0,31</td>
                </tr>
                <tr>
                  <td>Porcentagem de pacientes ap&#243;s evento cardiovascular agudo (&lt;12 semanas) por m&#234;s (por programa)</td>
                  <td align="center">20 (20 - 30)</td>
                  <td align="center">15 (0 - 25)</td>
                  <td align="center">10 (5 - 30)</td>
                  <td align="center">20 (20 - 30)</td>
                  <td align="center">-</td>
                  <td align="center" rowspan="2">1.817</td>
                  <td align="center" rowspan="2">0,30</td>
                </tr>
                <tr>
                  <td>N&#250;mero de pacientes ap&#243;s evento cardiovascular agudo (&lt;12 semanas) por m&#234;s (por programa)</td>
                  <td align="center">220 (12,1)</td>
                  <td align="center">557 (30,7)</td>
                  <td align="center">230 (12,7)</td>
                  <td align="center">810 (44,6)</td>
                  <td align="center">-</td>
                </tr>
                <tr>
                  <td>Pacientes do PRC usu&#225;rios do sistema p&#250;blico de sa&#250;de (por programa)</td>
                  <td align="center">0 (0 - 0)</td>
                  <td align="center">5 (0 - 45)</td>
                  <td align="center">25 (0 - 25)</td>
                  <td align="center">70 (0 - 70)</td>
                  <td align="center">-</td>
                  <td align="center">1.173</td>
                  <td align="center">0,48</td>
                </tr>
                <tr>
                  <td colspan="2">Hospitaliza&#231;&#245;es por DCV em mar&#231;o de 2020<sup>29</sup></td>
                  <td align="center">6.778 (7,4)</td>
                  <td align="center">20.127 (22)</td>
                  <td align="center">20.395 (22,3)</td>
                  <td align="center">39.573 (43,3)</td>
                  <td align="center">4.358 (4,7)</td>
                  <td align="center">91.231</td>
                  <td align="center">-</td>
                </tr>
                <tr>
                  <td colspan="2">Pacientes ap&#243;s evento agudo/pacientes internados por DCV em mar&#231;o de 2020 (%)</td>
                  <td align="center">3,24</td>
                  <td align="center">2,76</td>
                  <td align="center">1,12</td>
                  <td align="center">2,04</td>
                  <td align="center">0</td>
                  <td align="center">1,99</td>
                  <td align="center">-</td>
                </tr>
                <tr>
                  <td colspan="2" rowspan="3">
                    <bold>Caracter&#237;sticas cl&#237;nicas</bold>
                  </td>
                  <td align="center" colspan="5">
                    <bold>Regi&#227;o brasileira</bold>
                  </td>
                  <td align="center" rowspan="3">
                    <bold>Total</bold>
                  </td>
                  <td align="center" rowspan="3">
                    <bold>p</bold>
                  </td>
                </tr>
                <tr>
                  <td align="center" colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">
                    <bold>Centro-oeste</bold>
                  </td>
                  <td align="center">
                    <bold>Nordeste</bold>
                  </td>
                  <td align="center">
                    <bold>Sul</bold>
                  </td>
                  <td align="center">
                    <bold>Sudeste</bold>
                  </td>
                  <td align="center">
                    <bold>Norte</bold>
                  </td>
                </tr>
                <tr>
                  <td rowspan="14">N&#250;mero (%) de programas direcionados a condi&#231;&#245;es espec&#237;ficas</td>
                  <td>Insufici&#234;ncia card&#237;aca</td>
                  <td align="center">8 (88,9)</td>
                  <td align="center">8 (100)</td>
                  <td align="center">9 (75)</td>
                  <td align="center">30 (100)</td>
                  <td align="center">0</td>
                  <td align="center">55 (98)</td>
                  <td align="center">0,02</td>
                </tr>
                <tr>
                  <td>Revasculariza&#231;&#227;o coron&#225;ria</td>
                  <td align="center">8 (88,9)</td>
                  <td align="center">7 (87,5)</td>
                  <td align="center">9 (75)</td>
                  <td align="center">29 (96,7)</td>
                  <td align="center">0</td>
                  <td align="center">53 (89)</td>
                  <td align="center">0,21</td>
                </tr>
                <tr>
                  <td>Ap&#243;s implante de marca-passo e/ou CDI</td>
                  <td align="center">6 (66,7)</td>
                  <td align="center">6 (75)</td>
                  <td align="center">7 (58,3)</td>
                  <td align="center">25 (83,3)</td>
                  <td align="center">0</td>
                  <td align="center">44 (74)</td>
                  <td align="center">0,36</td>
                </tr>
                <tr>
                  <td>Doen&#231;a coronariana est&#225;vel</td>
                  <td align="center">6 (66,7)</td>
                  <td align="center">5 (62,5)</td>
                  <td align="center">6 (500</td>
                  <td align="center">25 (83,3)</td>
                  <td align="center">0</td>
                  <td align="center">42 (71)</td>
                  <td align="center">0,16</td>
                </tr>
                <tr>
                  <td>S&#237;ndrome coronariana aguda</td>
                  <td align="center">7 (77,8)</td>
                  <td align="center">5 (62,5)</td>
                  <td align="center">7 (58,3)</td>
                  <td align="center">22 (73,3)</td>
                  <td align="center">0</td>
                  <td align="center">41 (69)</td>
                  <td align="center">0,70</td>
                </tr>
                <tr>
                  <td>S&#237;ndrome metab&#243;lica</td>
                  <td align="center">7 (77,8)</td>
                  <td align="center">5 (62,5)</td>
                  <td align="center">6 (50)</td>
                  <td align="center">23 (76,7)</td>
                  <td align="center">0</td>
                  <td align="center">41 (69)</td>
                  <td align="center">0,34</td>
                </tr>
                <tr>
                  <td>Diabetes</td>
                  <td align="center">6 (66,7)</td>
                  <td align="center">4 (50)</td>
                  <td align="center">6 (50)</td>
                  <td align="center">23 (76,7)</td>
                  <td align="center">0</td>
                  <td align="center">39 (66)</td>
                  <td align="center">0,28</td>
                </tr>
                <tr>
                  <td>P&#243;s-cirurgia valvar</td>
                  <td align="center">5 (55,6)</td>
                  <td align="center">4 (50)</td>
                  <td align="center">5 (41,7)</td>
                  <td align="center">21 (70)</td>
                  <td align="center">0</td>
                  <td align="center">35 (59)</td>
                  <td align="center">0,34</td>
                </tr>
                <tr>
                  <td>DAOP</td>
                  <td align="center">2 (22,2)</td>
                  <td align="center">3 (37,5)</td>
                  <td align="center">6 (50)</td>
                  <td align="center">18 (60)</td>
                  <td align="center">0</td>
                  <td align="center">30 (50)</td>
                  <td align="center">0,21</td>
                </tr>
                <tr>
                  <td>Cardiopatias cong&#234;nitas no adulto</td>
                  <td align="center">3 (33,3)</td>
                  <td align="center">2 (25)</td>
                  <td align="center">0 (0)</td>
                  <td align="center">11 (36,7)</td>
                  <td align="center">0</td>
                  <td align="center">16 (27)</td>
                  <td align="center">0,11</td>
                </tr>
                <tr>
                  <td>P&#243;s-transplante card&#237;aco ou DAV</td>
                  <td align="center">0 (0)</td>
                  <td align="center">2 (25)</td>
                  <td align="center">1 (8,3)</td>
                  <td align="center">13 (43,3)</td>
                  <td align="center">0</td>
                  <td align="center">16 (27)</td>
                  <td align="center">0,02</td>
                </tr>
                <tr>
                  <td>Outros</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">3 (37,5)</td>
                  <td align="center">2 (16,7)</td>
                  <td align="center">7 (23,3)</td>
                  <td align="center">0</td>
                  <td align="center">13 (22)</td>
                  <td align="center">0,51</td>
                </tr>
                <tr>
                  <td>P&#243;s-evento cerebrovascular</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">1 (12,5)</td>
                  <td align="center">1 (8,3)</td>
                  <td align="center">9 (30)</td>
                  <td align="center">0</td>
                  <td align="center">12 (20)</td>
                  <td align="center">0,31</td>
                </tr>
                <tr>
                  <td>Pr&#233;-operat&#243;rio de cirurgia card&#237;aca</td>
                  <td align="center">0 (0)</td>
                  <td align="center">0(0)</td>
                  <td align="center">1 (8,3)</td>
                  <td align="center">2 (6,7)</td>
                  <td align="center">0</td>
                  <td align="center">3 (5)</td>
                  <td align="center">0,72</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN1">
                <p>
                  <italic>Dados expressos em n&#250;mero absoluto (n) e porcentagem (%) para vari&#225;veis categ&#243;ricas e em mediana e intervalo interquartil (25-75%) para vari&#225;veis cont&#237;nuas. A compara&#231;&#227;o entre grupos foi analisada por X<sup><italic>2</italic></sup> de Pearson (p&lt; 0,05). IIQ: intervalo interquartil; N: n&#250;mero; *: risco baixo, moderado ou alto, segundo diretriz Brasileira<sup><italic>26</italic></sup> ; PRC: Programa de reabilita&#231;&#227;o card&#237;aca; DCV: doen&#231;a cardiovascular; p-valor: teste qui-quadrado de Pearson; CDI: cardiodesfibrilador implant&#225;vel; DAOP: doen&#231;a arterial obstrutiva perif&#233;rica; DAV: dispositivo de assist&#234;ncia ventricular.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
        <p>A maioria dos PRCs participantes do estudo (n=44, 74%) estavam localizados em quatro estados brasileiros, os quais apresentavam o maior &#205;ndice de Desenvolvimento Humano (IDH) (acima de 0,731), de acordo com a literatura.<sup><xref ref-type="bibr" rid="B21">21</xref></sup> Considerando a taxa m&#233;dia de infec&#231;&#227;o por COVID-19 para o per&#237;odo avaliado (28,3 por 100 000 habitantes), tr&#234;s desses quatro estados estavam acima do n&#250;mero calculado ( <xref ref-type="fig" rid="f01">Figura 1</xref> ). Segundo dados dispon&#237;veis na literatura,<sup><xref ref-type="bibr" rid="B21">21</xref></sup> a regi&#227;o N apresentava o segundo pior IDH no Brasil (0,667) e foi a &#250;nica regi&#227;o em que n&#227;o houve nenhum respondente ao question&#225;rio. Por outro lado, a regi&#227;o SE que tem o maior IDH do pa&#237;s (0,766),<sup><xref ref-type="bibr" rid="B21">21</xref></sup> a maior concentra&#231;&#227;o de PRCs (30/59), o programa mais antigo (238 meses), a maior taxa de pacientes tratados por programa (78%), e o maior n&#250;mero de pacientes assistidos pelo sistema p&#250;blico de sa&#250;de (SUS) (70%).</p>
        <p>
          <fig id="f01">
            <label>Figura 1</label>
            <caption>
              <title>&#8211; N&#250;mero de programas de reabilita&#231;&#227;o cardiovascular e taxa de infec&#231;&#227;o pelo novo coronav&#237;rus (COVID-19) antes e ap&#243;s a primeira onda da doen&#231;a (20 a 30 de abril de 2020), e &#205;ndice de Desenvolvimento Humano (IDH) por unidade federativa e regi&#227;o do Brasil.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-120-03-e20220135-20135-gf01.tif"/></fig>
        </p>
        <p>De acordo com o n&#250;mero de interna&#231;&#245;es por doen&#231;as cardiovasculares no Brasil em mar&#231;o de 2020 (n=91.231), e a disponibilidade de programas para pacientes ap&#243;s os eventos cardiovasculares agudos (n=1.817), somente 1,99% dos pacientes puderam ser tratados em PRCs. O pior cen&#225;rio ocorreu na regi&#227;o S (n&#250;mero de programas/n&#250;mero de pacientes: 230/20.395: 1,12%), seguido da regi&#227;o SE (810/39.573: 2,04%) ( <xref ref-type="table" rid="t1">Tabela 1</xref> ).</p>
        <p>Quanto &#224;s caracter&#237;sticas cl&#237;nicas, a insufici&#234;ncia card&#237;aca (IC) foi a condi&#231;&#227;o cl&#237;nica mais descrita pelos coordenadores de PRCs (n=55, 93,2%), seguido de revasculariza&#231;&#227;o coronariana (n=53, 89,8%) e pacientes com marca-passo ou desfibrilador card&#237;aco implant&#225;vel (n=44, 74,5%) ( <xref ref-type="table" rid="t1">Tabela 1</xref> ). Contudo, a porcentagem de programas direcionados a pacientes com IC foi diferente entre as regi&#245;es geogr&#225;ficas do Brasil. Enquanto 100% dos PRCs nas regi&#245;es NE e SE atendiam pacientes com IC, somente 89% e 75% dos programas nas regi&#245;es CO e S, respectivamente, eram direcionados a esses pacientes (p=0,02) ( <xref ref-type="table" rid="t1">Tabela 1</xref> ). Nenhum dos programas da regi&#227;o CO atendia pacientes no p&#243;s-transplante card&#237;aco e/ou usu&#225;rios de suporte ventricular; por outro lado, 43,3% dos PRCs na regi&#227;o SE atendia pacientes no p&#243;s-transplante (p=0,02) ( <xref ref-type="table" rid="t1">Tabela 1</xref> ).</p>
        <p>Encontramos discrep&#226;ncias importantes quanto aos componentes chave empregados por PRCs entre as regi&#245;es. Aconselhamento nutricional foi oferecido em um programa (11%) na regi&#227;o CO, e em 19 programas (63,3%) na regi&#227;o SE (p=0,005) ( <xref ref-type="table" rid="t2">Tabela 2</xref> ). Suporte vocacional foi o componente menos oferecido no Brasil (n= 1, 8,3%), ao passo que orienta&#231;&#227;o sobre exerc&#237;cio (n=59, 100%) e atividade f&#237;sica (n=57, 96%) foram os componentes mais frequentes ( <xref ref-type="table" rid="t2">Tabela 2</xref> ).</p>
        <p>
          <table-wrap id="t2">
            <label>Tabela 2</label>
            <caption>
              <title>&#8211; Caracter&#237;sticas operacionais dos programas de reabilita&#231;&#227;o card&#237;aca antes do primeiro caso de COVID-19 confirmado no Brasil e interna&#231;&#245;es por doen&#231;as cardiovasculares por regi&#227;o brasileira</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" colspan="2" rowspan="3" scope="col">Caracter&#237;sticas operacionais</th>
                  <th colspan="6" scope="col">Regi&#227;o brasileira</th>
                  <th rowspan="3" scope="col">Total</th>
                  <th rowspan="3" scope="col">p</th>
                </tr>
                <tr>
                  <th colspan="6" scope="col">
                    <hr/>
                  </th>
                </tr>
                <tr>
                  <th scope="col">Centro-oeste</th>
                  <th scope="col">Nordeste</th>
                  <th scope="col">Sul</th>
                  <th colspan="2" scope="col">Sudeste</th>
                  <th scope="col">Norte</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="8">N&#250;mero (%) de programas que ofereceram componentes centrais</td>
                  <td align="left">Exerc&#237;cios</td>
                  <td align="center">9 (100)</td>
                  <td align="center">8 (100)</td>
                  <td align="center" colspan="2">30 (100)</td>
                  <td align="center">12 (100)</td>
                  <td align="center">0</td>
                  <td align="center">59 (100)</td>
                  <td align="center">1</td>
                </tr>
                <tr>
                  <td align="left">Aconselhamento nutricional</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">6 (75)</td>
                  <td align="center" colspan="2">10 (83,3)</td>
                  <td align="center">19 (63,3)</td>
                  <td align="center">0</td>
                  <td align="center">36 (61)</td>
                  <td align="center">0,005</td>
                </tr>
                <tr>
                  <td align="left">Controle de fatores de risco</td>
                  <td align="center">7 (77,8)</td>
                  <td align="center">7 (87,5)</td>
                  <td align="center" colspan="2">9 (75)</td>
                  <td align="center">26 (86,7)</td>
                  <td align="center">0</td>
                  <td align="center">49 (83)</td>
                  <td align="center">0,07</td>
                </tr>
                <tr>
                  <td align="left">Cessa&#231;&#227;o do tabagismo</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">2 (25)</td>
                  <td align="center" colspan="2">3 (25)</td>
                  <td align="center">9 (30)</td>
                  <td align="center">0</td>
                  <td align="center">15 (25)</td>
                  <td align="center">0,72</td>
                </tr>
                <tr>
                  <td align="left">Suporte psicol&#243;gico</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">3 (37,5)</td>
                  <td align="center" colspan="2">5 (41,7)</td>
                  <td align="center">12 (40)</td>
                  <td align="center">0</td>
                  <td align="center">21(35)</td>
                  <td align="center">0,42</td>
                </tr>
                <tr>
                  <td align="left">Orienta&#231;&#227;o sobre atividade f&#237;sica</td>
                  <td align="center">8 (88,9)</td>
                  <td align="center">8 (100)</td>
                  <td align="center" colspan="2">11(91,7)</td>
                  <td align="center">30 (100)</td>
                  <td align="center">0</td>
                  <td align="center">57 (96)</td>
                  <td align="center">0,27</td>
                </tr>
                <tr>
                  <td align="left">Orienta&#231;&#227;o vocacional</td>
                  <td align="center">0 (0)</td>
                  <td align="center">0 (0)</td>
                  <td align="center" colspan="2">1 (8,3)</td>
                  <td align="center">0 (0)</td>
                  <td align="center">0</td>
                  <td align="center">1 (1)</td>
                  <td align="center">0,80</td>
                </tr>
                <tr>
                  <td>Controle de ades&#227;o ao tratamento</td>
                  <td align="center">7 (77,8)</td>
                  <td align="center">7 (87,5)</td>
                  <td align="center" colspan="2">8 (66,7)</td>
                  <td align="center">25 (83,3)</td>
                  <td align="center">0</td>
                  <td align="center">47 (79)</td>
                  <td align="center">0,61</td>
                </tr>
                <tr>
                  <td rowspan="9">M&#233;todos de avalia&#231;&#227;o usados pelos programas <italic>n (%)</italic></td>
                  <td>Teste cardiopulmonar de exerc&#237;cio</td>
                  <td align="center">4 (44,4)</td>
                  <td align="center">7 (87,5)</td>
                  <td align="center" colspan="2">6 (50)</td>
                  <td align="center">20 (66,7)</td>
                  <td align="center">0</td>
                  <td align="center">37 (62)</td>
                  <td align="center">0,22</td>
                </tr>
                <tr>
                  <td>Teste de caminhada de 6 minutos</td>
                  <td align="center">7 (77,8)</td>
                  <td align="center">4 (50)</td>
                  <td align="center" colspan="2">11(91,7)</td>
                  <td align="center">17 (56,7)</td>
                  <td align="center">0</td>
                  <td align="center">39 (66)</td>
                  <td align="center">0,10</td>
                </tr>
                <tr>
                  <td>Teste de levantar e sentar</td>
                  <td align="center">3 (33,3)</td>
                  <td align="center">4 (50)</td>
                  <td align="center" colspan="2">7 (58,3)</td>
                  <td align="center">12 (40)</td>
                  <td align="center">0</td>
                  <td align="center">26 (44)</td>
                  <td align="center">0,36</td>
                </tr>
                <tr>
                  <td>Teste de preens&#227;o manual</td>
                  <td align="center">2 (22,2)</td>
                  <td align="center">3 (37,5)</td>
                  <td align="center" colspan="2">6 (50)</td>
                  <td align="center">9 (30)</td>
                  <td align="center">0</td>
                  <td align="center">20 (33)</td>
                  <td align="center">0,53</td>
                </tr>
                <tr>
                  <td>For&#231;a muscular respirat&#243;ria</td>
                  <td align="center">4 (44,4)</td>
                  <td align="center">6 (75)</td>
                  <td align="center" colspan="2">7 (58,3)</td>
                  <td align="center">17 (56,7)</td>
                  <td align="center">0</td>
                  <td align="center">34 (57)</td>
                  <td align="center">0,65</td>
                </tr>
                <tr>
                  <td>Teste de flexibilidade</td>
                  <td align="center">3 (33,3)</td>
                  <td align="center">3 (37,5)</td>
                  <td align="center" colspan="2">4 (33,3)</td>
                  <td align="center">14 (46,7)</td>
                  <td align="center">0</td>
                  <td align="center">24 (40)</td>
                  <td align="center">0,81</td>
                </tr>
                <tr>
                  <td>Mobilidade funcional &#8211; teste <italic>timed up and go</italic></td>
                  <td align="center">2 (22,2)</td>
                  <td align="center">1(12,52)</td>
                  <td align="center" colspan="2">4 (33,3)</td>
                  <td align="center">8 (26,7)</td>
                  <td align="center">0</td>
                  <td align="center">15 (25)</td>
                  <td align="center">0,75</td>
                </tr>
                <tr>
                  <td>Avalia&#231;&#227;o do equil&#237;brio &#8211; tese de Berg</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">2 (25)</td>
                  <td align="center" colspan="2">1 (8,3)</td>
                  <td align="center">9 (30)</td>
                  <td align="center">0</td>
                  <td align="center">13 (22)</td>
                  <td align="center">0,37</td>
                </tr>
                <tr>
                  <td>Avalia&#231;&#227;o da qualidade de vida</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">2 (25)</td>
                  <td align="center" colspan="2">1 (8,3)</td>
                  <td align="center">2 (6,7)</td>
                  <td align="center">0</td>
                  <td align="center">6 (10)</td>
                  <td align="center">0,49</td>
                </tr>
                <tr>
                  <td rowspan="7">Tipos de treinamento oferecidos pelos programas <italic>n (%)</italic></td>
                  <td>Treinamento de coordena&#231;&#227;o motora</td>
                  <td align="center">4 (44,4)</td>
                  <td align="center">5 (62,5)</td>
                  <td align="center" colspan="2">6 (50)</td>
                  <td align="center">25 (83,3)</td>
                  <td align="center">0</td>
                  <td align="center">40 (68)</td>
                  <td align="center">0,06</td>
                </tr>
                <tr>
                  <td>Treino de equil&#237;brio</td>
                  <td align="center">5 (55,6)</td>
                  <td align="center">6 (75)</td>
                  <td align="center" colspan="2">8 (66,7)</td>
                  <td align="center">27 (90)</td>
                  <td align="center">0</td>
                  <td align="center">46 (78)</td>
                  <td align="center">0,10</td>
                </tr>
                <tr>
                  <td>Alongamento</td>
                  <td align="center">8 (88,9)</td>
                  <td align="center">8 (100)</td>
                  <td align="center" colspan="2">12 (100)</td>
                  <td align="center">30 (100)</td>
                  <td align="center">0</td>
                  <td align="center">58 (98)</td>
                  <td align="center">0,13</td>
                </tr>
                <tr>
                  <td>Treinamento muscular respirat&#243;rio de intensidade moderada</td>
                  <td align="center">2 (22,2)</td>
                  <td align="center">6 (75)</td>
                  <td align="center" colspan="2">6 (50)</td>
                  <td align="center">17 (56,7)</td>
                  <td align="center">0</td>
                  <td align="center">31 (53)</td>
                  <td align="center">0,16</td>
                </tr>
                <tr>
                  <td>Treinamento de resist&#234;ncia de intensidade moderada</td>
                  <td align="center">7 (77,8)</td>
                  <td align="center">7 (87,5)</td>
                  <td align="center" colspan="2">11 (91,7)</td>
                  <td align="center">28 (93,3)</td>
                  <td align="center">0</td>
                  <td align="center">53 (90)</td>
                  <td align="center">0,58</td>
                </tr>
                <tr>
                  <td>Treino intervalado de alta intensidade</td>
                  <td align="center">5 (55,6)</td>
                  <td align="center">6 (75)</td>
                  <td align="center" colspan="2">4 (33,3)</td>
                  <td align="center">17 (56,7)</td>
                  <td align="center">0</td>
                  <td align="center">32 (54)</td>
                  <td align="center">0,31</td>
                </tr>
                <tr>
                  <td>Treinamento cont&#237;nuo de intensidade moderada</td>
                  <td align="center">8 (88,9)</td>
                  <td align="center">8 (100)</td>
                  <td align="center" colspan="2">11 (91,7)</td>
                  <td align="center">30 (100)</td>
                  <td align="center">0</td>
                  <td align="center">57 (97)</td>
                  <td align="center">0,27</td>
                </tr>
                <tr>
                  <td rowspan="6">Estrat&#233;gias usadas para oferecer reabilita&#231;&#227;o card&#237;aca remota <italic>n (%)</italic></td>
                  <td>Chamadas telef&#244;nicas</td>
                  <td align="center">2 (22,2)</td>
                  <td align="center">3 (37,5)</td>
                  <td align="center" colspan="2">4 (33,3)</td>
                  <td align="center">11 (36,7)</td>
                  <td align="center">0</td>
                  <td align="center">20 (33)</td>
                  <td align="center">0,87</td>
                </tr>
                <tr>
                  <td>Aplicativo ou software para PRC</td>
                  <td align="center">0 (0)</td>
                  <td align="center">0 (0)</td>
                  <td align="center" colspan="2">0 (0)</td>
                  <td align="center">0 (0)</td>
                  <td align="center">0</td>
                  <td align="center">0 (0)</td>
                  <td align="center">1,00</td>
                </tr>
                <tr>
                  <td>Suporte de m&#237;dia (v&#237;deos e fotos)</td>
                  <td align="center">0 (0)</td>
                  <td align="center">1 (12,5)</td>
                  <td align="center" colspan="2">2 (16,7)</td>
                  <td align="center">5 (16,7)</td>
                  <td align="center">0</td>
                  <td align="center">8 (13)</td>
                  <td align="center">0,62</td>
                </tr>
                <tr>
                  <td>Material promocional</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">1 (12,5)</td>
                  <td align="center" colspan="2">2 (16,7)</td>
                  <td align="center">11 (36,7)</td>
                  <td align="center">0</td>
                  <td align="center">16 (27)</td>
                  <td align="center">0,24</td>
                </tr>
                <tr>
                  <td>Chamadas por v&#237;deo</td>
                  <td align="center">0 (0)</td>
                  <td align="center">1 (12,5)</td>
                  <td align="center" colspan="2">2 (16,7)</td>
                  <td align="center">4 (13,3)</td>
                  <td align="center">0</td>
                  <td align="center">7 (11)</td>
                  <td align="center">0,67</td>
                </tr>
                <tr>
                  <td>Outros</td>
                  <td align="center">1 (11,1)</td>
                  <td align="center">1 (12,5)</td>
                  <td align="center" colspan="2">1 (8,3)</td>
                  <td align="center">4 (13,3)</td>
                  <td align="center">0</td>
                  <td align="center">7 (11)</td>
                  <td align="center">0,97</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN2">
                <p>
                  <italic>Dados expressos em n&#250;mero absoluto (n) e porcentagem (%) para vari&#225;veis categ&#243;ricas; compara&#231;&#245;es entre grupos foram analisadas pelo teste de Kruskal-Wallis (p&lt;0,05); PRC: Programa de reabilita&#231;&#227;o cardiovascular; p-valor: teste de Kruskal-Wallis.</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
        <p>As principais modalidades de exerc&#237;cios presenciais oferecidas nos PRCs foram alongamento (98%), treinamento aer&#243;bico cont&#237;nuo de intensidade moderada (97%), e treinamento de resist&#234;ncia de intensidade moderada (90%) ( <xref ref-type="table" rid="t2">Tabela 2</xref> ). Nenhum dos 59 programas utilizava software ou aplicativo espec&#237;fico de RC antes da pandemia da COVID-19; chamadas telef&#244;nicas (n=20, 33%) e materiais promocionais (n=16, 27%) eram as iniciativas remotas mais prevalentes antes da pandemia ( <xref ref-type="table" rid="t2">Tabela 2</xref> ).</p>
      </sec>
      <sec>
        <title>Impacto da COVID-19 sobre programas de reabilita&#231;&#227;o cardiovascular no Brasil</title>
        <p>De acordo com a m&#233;dia nacional de infec&#231;&#227;o por COVID-19, os estados brasileiros foram diferentemente afetados em abril de 2020 (28,3 por 100,000 habitantes). Na regi&#227;o SE, 23 (63,9%) dos PRCs ocorreram em cidades com uma taxa de infec&#231;&#227;o acima da m&#233;dia nacional, enquanto 5,6% dos PRCs na regi&#227;o S, 19,4% na regi&#227;o CO, e 11,1% na regi&#227;o NE foram conduzidos em cidades com uma taxa de infec&#231;&#227;o acima da m&#233;dia nacional (p=0,002) ( <xref ref-type="table" rid="t3">Tabela 3</xref> ).</p>
        <p>
          <table-wrap id="t3">
            <label>Tabela 3</label>
            <caption>
              <title>&#8211; Local do programa de reabilita&#231;&#227;o cardiovascular de acordo com a taxa nacional m&#233;dia de COVID-19 19 (&gt; ou &#8804;28,3 por 100000 habitantes) por regi&#227;o brasileira e os principais impactos dos programas nos primeiros 60 dias ap&#243;s o primeiro caso de COVID-19 no Brasil</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" rowspan="5" scope="col">Regi&#245;es brasileiras/ Impactos da pandemia</th>
                  <th colspan="5" scope="col">Taxa nacional m&#233;dia de COVID calculada nos primeiros 60 dias da pandemia</th>
                  <th align="left" colspan="2" rowspan="4" scope="col" style="font-weight:normal"> </th>
                  <th rowspan="5" scope="col">Teste do qui-quadrado de Pearson</th>
                </tr>
                <tr>
                  <th colspan="5" scope="col">
                    <hr/>
                  </th>
                </tr>
                <tr>
                  <th colspan="3" scope="col">&lt; = 28,3 por 100 000 habitantes</th>
                  <th colspan="2" scope="col">&gt; 28,3 por 100 000 habitantes</th>
                </tr>
                <tr>
                  <th colspan="5" rowspan="1" scope="col">
                    <hr/>
                  </th>
                </tr>
                <tr>
                  <th colspan="2" scope="col">n</th>
                  <th scope="col">%</th>
                  <th scope="col">n</th>
                  <th scope="col">%</th>
                  <th align="left" scope="col" style="font-weight:normal">Total (n)</th>
                  <th align="left" scope="col" style="font-weight:normal">Total (%)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left">Centro-oeste</td>
                  <td align="center">2</td>
                  <td align="center" colspan="2">8,7</td>
                  <td align="center">7</td>
                  <td align="center">19,4</td>
                  <td align="center">9</td>
                  <td align="center">15,2</td>
                  <td colspan="1" rowspan="5">p = 0,002</td>
                </tr>
                <tr>
                  <td align="left">Nordeste</td>
                  <td align="center">4</td>
                  <td align="center" colspan="2">17,4</td>
                  <td align="center">4</td>
                  <td align="center">11,1</td>
                  <td align="center">8</td>
                  <td align="center">13,6</td>
                </tr>
                <tr>
                  <td align="left">Sudeste</td>
                  <td align="center">7</td>
                  <td align="center" colspan="2">30,4</td>
                  <td align="center">23</td>
                  <td align="center">63,9</td>
                  <td align="center">30</td>
                  <td align="center">50,9</td>
                </tr>
                <tr>
                  <td align="left">Sul</td>
                  <td align="center">10</td>
                  <td align="center" colspan="2">43,5</td>
                  <td align="center">2</td>
                  <td align="center">5,6</td>
                  <td align="center">12</td>
                  <td align="center">20,3</td>
                </tr>
                <tr>
                  <td align="left">
                    <italic>Total</italic>
                  </td>
                  <td align="center">
                    <italic>23</italic>
                  </td>
                  <td align="center" colspan="2">
                    <italic>100</italic>
                  </td>
                  <td align="center">
                    <italic>36</italic>
                  </td>
                  <td align="center">
                    <italic>100</italic>
                  </td>
                  <td align="center">59</td>
                  <td align="center">100</td>
                </tr>
                <tr>
                  <td align="left">Encerramento do programa</td>
                  <td align="center">2</td>
                  <td align="center" colspan="2">8,7</td>
                  <td align="center">1</td>
                  <td align="center">2,8</td>
                  <td align="center">3</td>
                  <td align="center">5</td>
                  <td colspan="1" rowspan="6">p = 0,09</td>
                </tr>
                <tr>
                  <td>Interrup&#231;&#227;o do programa</td>
                  <td align="center">15</td>
                  <td align="center" colspan="2">65,2</td>
                  <td align="center">30</td>
                  <td align="center">83,3</td>
                  <td align="center">45</td>
                  <td align="center">76,3</td>
                </tr>
                <tr>
                  <td>Redu&#231;&#227;o no n&#250;mero de sess&#245;es</td>
                  <td align="center">6</td>
                  <td align="center" colspan="2">26,1</td>
                  <td align="center">2</td>
                  <td align="center">5,6</td>
                  <td align="center">8</td>
                  <td align="center">13,6</td>
                </tr>
                <tr>
                  <td>Funcionamento normal do programa</td>
                  <td align="center">0</td>
                  <td align="center" colspan="2">0</td>
                  <td align="center">1</td>
                  <td align="center">2,8</td>
                  <td align="center">1</td>
                  <td align="center">1,7</td>
                </tr>
                <tr>
                  <td>Outros</td>
                  <td align="center">0</td>
                  <td align="center" colspan="2">0</td>
                  <td align="center">2</td>
                  <td align="center">5,5</td>
                  <td align="center">2</td>
                  <td align="center">3,4</td>
                </tr>
                <tr>
                  <td>
                    <bold>
                      <italic>Total</italic>
                    </bold>
                  </td>
                  <td align="center">
                    <italic>23</italic>
                  </td>
                  <td align="center" colspan="2">
                    <italic>100</italic>
                  </td>
                  <td align="center">
                    <italic>36</italic>
                  </td>
                  <td align="center">
                    <italic>100</italic>
                  </td>
                  <td align="center">59</td>
                  <td align="center">100</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN3">
                <p>
                  <italic>Vari&#225;veis categ&#243;ricas expressas em n&#250;mero absoluto (n) e porcentagem (%). Compara&#231;&#227;o entre grupos analisada por teste qui-quadrado de Pearson (p&lt; 0,05).</italic>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
        <p>O maior impacto da pandemia da COVID-19 sobre os PRCs foram as restri&#231;&#245;es comerciais na cidade, que ocorreram independentemente da taxa de infec&#231;&#227;o local, j&#225; que 30 dos 36 (83,3%) programas foram realizados em cidades com uma taxa acima da m&#233;dia, e 15 dos 23 (65,2%) programas eram em cidades com uma taxa abaixo da m&#233;dia ( <xref ref-type="table" rid="t3">Tabela 3</xref> ).</p>
        <p>Uma redu&#231;&#227;o no n&#250;mero de sess&#245;es de RC foi o segundo maior impacto, observada em 26,1% das cidades com as maiores taxas de infec&#231;&#227;o por COVID-19, e em 5,6% das cidades com as taxas mais baixas de infec&#231;&#227;o por COVID-19 (p=0,097) ( <xref ref-type="table" rid="t3">Tabela 3</xref> ).</p>
        <p>As principais adapta&#231;&#245;es feitas pelos programas que continuaram a oferecer sess&#245;es de RC durante a pandemia foram: 1) oferecer servi&#231;os remotos (n=18, 31%), 2) mudan&#231;as nas atribui&#231;&#245;es dos profissionais de sa&#250;de (n=11, 19%), 3) redu&#231;&#227;o nas horas de trabalho dos profissionais de sa&#250;de (n=10, 17%) e 4) redu&#231;&#227;o no</p>
        <p>n&#250;mero de sess&#245;es (n=9, 15%) ( <xref ref-type="fig" rid="f02">Figura 2</xref> ). As estrat&#233;gias mais utilizadas para facilitar as sess&#245;es remotas durante a pandemia foi utilizado de v&#237;deos e fotos (aumento de 3 para 17 programas, p=0,007) e chamadas por v&#237;deo (aumento de 3 para 12 programas, p = 0,017) ( <xref ref-type="fig" rid="f03">Figura 3</xref> ).</p>
        <p>
          <fig id="f02">
            <label>Figura 2</label>
            <caption>
              <title>&#8211; Principais mudan&#231;as observadas e esperadas nos Programas de Reabilita&#231;&#227;o Cardiovascular (PRCs), impostas pela pandemia da COVID-19, e percep&#231;&#227;o dos profissionais dos PRCs sobre o manejo dos pacientes com COVID-19 durante a primeira onda da pandemia (20 a 30 de abril de 2020) no Brasil.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-120-03-e20220135-20135-gf02.tif"/></fig>
        </p>
        <p>
          <fig id="f03">
            <label>Figura 3</label>
            <caption>
              <title>&#8211; Estrat&#233;gias usadas para oferecer programas de reabilita&#231;&#227;o card&#237;aca remota durante a primeira onda de COVID-19 (20 a 30 de abril de 2020) nos Brasil; teste de McNemar, p&lt;0,05; PRCs: Programas de Reabilita&#231;&#227;o Cardiovascular.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-120-03-e20220135-20135-gf03.tif"/></fig>
        </p>
        <p>Somente 17 coordenadores dos PRCs relataram que os profissionais sentiam-se preparados para prover RC face as novas restri&#231;&#245;es durante o per&#237;odo da pandemia, e somente tr&#234;s PRCs (5,08%) admitiram pacientes para RC ( <xref ref-type="fig" rid="f02">Figura 2</xref> ).</p>
        <p>A maioria dos participantes (93,22%) respondeu que o fato de receberem orienta&#231;&#245;es sobre manejo da RC durante a pandemia, foi importante para um direcionamento ou orienta&#231;&#227;o durante esse per&#237;odo. Ainda, 74,57% dos respondentes relataram necessidade de treinamento e qualifica&#231;&#227;o no manejo de PRCs, e 72,88% buscaram aplicativos <italic>online</italic> RC remoto ( <xref ref-type="fig" rid="f02">Figura 2</xref> ).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discuss&#227;o</title>
      <p>Este estudo fornece informa&#231;&#245;es sobre o impacto da COVID-19 nos primeiros 60 dias da pandemia (abril de 2020), destacando a redu&#231;&#227;o no n&#250;mero de programas dispon&#237;veis durante esse cr&#237;tico per&#237;odo. Tamb&#233;m identificamos as principais estrat&#233;gias dos PRCs para promover atividade f&#237;sica durante a pandemia. Segundo, apresentamos uma atualiza&#231;&#227;o das caracter&#237;sticas demogr&#225;ficas, cl&#237;nicas e operacionais dos PRCs no Brasil, mostrando as diferen&#231;as entre os servi&#231;os por regi&#227;o e reafirmando a necessidade por servi&#231;os de RC no Brasil.</p>
      <sec>
        <title>Programas de reabilita&#231;&#227;o cardiovascular antes da pandemia da COVID-19</title>
        <p>Dos 75 PRCs no Brasil, obtivemos informa&#231;&#245;es atualizadas sobre caracter&#237;sticas cl&#237;nicas e demogr&#225;ficas antes da pandemia da COVID-19 de 17 programas, e sobre o impacto de 59 programas, consistindo no maior n&#250;mero de PRCs avaliados por uma pesquisa no Brasil.</p>
        <p>Assim como relatado por Britto et al.,<sup><xref ref-type="bibr" rid="B17">17</xref></sup> n&#227;o obtivemos nenhum respondente da regi&#227;o N, o que nos impediu de caracterizar os PRCs desta regi&#227;o. No m&#234;s anterior &#224; pesquisa (mar&#231;o de 2020), houve 4358 admiss&#245;es hospitalares relacionadas &#224;s doen&#231;as cardiovasculares na regi&#227;o N,<sup><xref ref-type="bibr" rid="B18">18</xref></sup> o que refor&#231;a uma poss&#237;vel precariedade nessa regi&#227;o.</p>
        <p>Considerando o n&#250;mero de pacientes hospitalizados por doen&#231;as cardiovasculares em todas as regi&#245;es brasileiras no mesmo per&#237;odo, e a dura&#231;&#227;o m&#233;dia de 36 sess&#245;es para cada participante do PRC, encontramos taxas de participa&#231;&#227;o extremamente baixas, variando de 1,12% na regi&#227;o S a 3,24% na regi&#227;o CO. Esses n&#250;meros n&#227;o incluem a demanda anterior por PRCs de participantes n&#227;o hospitalizados com doen&#231;as cardiovasculares, o que devia ser ainda maior, j&#225; que a taxa de hospitaliza&#231;&#227;o por essas condi&#231;&#245;es &#233; estimada em 11,2% de acordo com uma recente revis&#227;o sistem&#225;tica.<sup><xref ref-type="bibr" rid="B22">22</xref></sup> A grande demanda por PRCs, combinada com o baixo n&#250;mero de PRCs dispon&#237;veis, torna clara a necessidade de investimentos nessa &#225;rea.</p>
        <p>Em rela&#231;&#227;o a doen&#231;as cardiovasculares, a IC foi a condi&#231;&#227;o mais frequentemente relatada. No entanto, &#233; poss&#237;vel que algumas doen&#231;as sejam menos mencionadas em PRCs dada sua alta complexidade, tais como o p&#243;s-transplante. Na regi&#227;o CO, por exemplo, pacientes no p&#243;s-transplante provavelmente n&#227;o sejam encaminhados a PRCs, e a aus&#234;ncia de cuidado a esses pacientes nessa regi&#227;o tamb&#233;m pode estar relacionada ao pequeno n&#250;mero de servi&#231;os p&#250;blicos dispon&#237;veis. Outra possibilidade &#233; que nem todos os programas na regi&#227;o CO tenham respondido o question&#225;rio. De qualquer maneira, pol&#237;ticas p&#250;blicas para aumentar o encaminhamento de pacientes e expandir o n&#250;mero de PRCs na regi&#227;o CO s&#227;o de extrema prioridade.</p>
        <p>Quanto &#224;s caracter&#237;sticas operacionais dos PRCs, nosso estudo identificou que o &#250;nico componente presente em 100% dos PRCs foi a pr&#225;tica de exerc&#237;cio f&#237;sico, o que foi compar&#225;vel a outros estudos.<sup><xref ref-type="bibr" rid="B23">23</xref></sup> Esse &#233; um achado preocupante, uma vez que espera-se que os PRCs ofere&#231;am todos os oito componentes essenciais: 1) exerc&#237;cio f&#237;sico, 2) aconselhamento nutricional, 3) controle de fator de risco, 4) cessa&#231;&#227;o do tabagismo, 5) suporte psicol&#243;gico, 6) aconselhamento de exerc&#237;cio f&#237;sico 7) orienta&#231;&#227;o vocacional e 8) controle e ades&#227;o ao tratamento.<sup><xref ref-type="bibr" rid="B11">11</xref></sup> Um estudo pr&#233;vio canadense demonstrou que o aconselhamento nutricional e a orienta&#231;&#227;o quanto a pr&#225;tica de atividade f&#237;sica s&#227;o oferecidos por todos os PRCs.<sup><xref ref-type="bibr" rid="B24">24</xref></sup> Outras inciativas p&#250;blicas e privadas, com foco na cobertura nacional dos servi&#231;os e treinamento profissional s&#227;o necess&#225;rias para fornecer todos os componentes necess&#225;rios e, assim, otimizar a assist&#234;ncia a pacientes com doen&#231;a cardiovascular no Brasil.</p>
      </sec>
      <sec>
        <title>Impactos da COVID-19 sobre programas de reabilita&#231;&#227;o cardiovascular</title>
        <p>A primeira estrat&#233;gia descrita para manter os participantes nos PRCs foi a introdu&#231;&#227;o de atividades remotas, principalmente chamadas por v&#237;deo (33%), seguido de utiliza&#231;&#227;o de fotos e v&#237;deos (27%). Um estudo pr&#233;vio apresentou resultados favor&#225;veis quanto a prescri&#231;&#227;o de exerc&#237;cios, ades&#227;o &#224; reabilita&#231;&#227;o, e mudan&#231;as de comportamento pelo uso de imagens e v&#237;deos.<sup><xref ref-type="bibr" rid="B25">25</xref></sup> Outros estudos tamb&#233;m apontaram a reabilita&#231;&#227;o remota como uma importante estrat&#233;gia para aumentar a disponibilidade de RC para pacientes com doen&#231;a coronariana.<sup><xref ref-type="bibr" rid="B26">26</xref></sup> Esperamos que esses recursos continuem a ser incorporados mesmo ap&#243;s a pandemia, j&#225; que aumentar a ades&#227;o e a cobertura da RC, bem como prover mais componentes centrais a um maior n&#250;mero de pacientes &#233; altamente recomendado na literatura.<sup><xref ref-type="bibr" rid="B27">27</xref> - <xref ref-type="bibr" rid="B29">29</xref></sup></p>
        <p>As atividades remotas t&#234;m sido oferecidas por diferentes abordagens. Aquelas que utilizam plataformas digitais (aplicativos ou softwares) e incluem a capacidade de monitoramento em tempo real parecem ser mais efetivas em aumentar a ades&#227;o do paciente e seu envolvimento em PRCs.<sup><xref ref-type="bibr" rid="B30">30</xref></sup> Em nosso estudo, somente dois PRCs utilizaram plataformas digitais durante a pandemia da COVID-19, refor&#231;ando a necessidade urgente de melhorar os investimentos e o conhecimento nessa &#225;rea, e aumentar a disponibilidade de recursos para pacientes no Brasil e provavelmente em muitos pa&#237;ses.</p>
        <p>Quanto ao impacto da pandemia da COVID-19 sobre os profissionais dos PRCs, encontramos que a maioria sentiam-se despreparados para os desafios apresentados pelas restri&#231;&#245;es impostas pelas COVID-19, e inseguros em prover RC durante a pandemia. Os profissionais da sa&#250;de relataram com frequ&#234;ncia medo de serem infectados ou de infectar seus familiares, e relataram estresse emocional por mudan&#231;as nos protocolos e uso de equipamentos de prote&#231;&#227;o.<sup><xref ref-type="bibr" rid="B31">31</xref></sup> Assim, &#233; evidente que a pandemia da COVID-19 tamb&#233;m tenha causado um impacto negativo nas rotinas dos profissionais da sa&#250;de, provavelmente interferindo na oferta, na administra&#231;&#227;o, e na disponibilidade dos PRCs.</p>
      </sec>
      <sec>
        <title>Limita&#231;&#245;es</title>
        <p>Este estudo teve algumas limita&#231;&#245;es, incluindo o fato de que nem todos os PRCs no Brasil tenham recebido a pesquisa <italic>online</italic> , que todas as quest&#245;es deveriam ter sido respondidas para que a pesquisa fosse inclu&#237;da no estudo, que uma ou mais quest&#245;es da pesquisa possam ter sido mal interpretadas, e que a taxa de infec&#231;&#227;o por COVID-19 possa ter sido subestimada.</p>
        <p>Al&#233;m disso, a natureza transversal deste estudo n&#227;o nos permite estabelecer nenhuma infer&#234;ncia causal. Ainda, embora tiv&#233;ssemos o apoio de v&#225;rias associa&#231;&#245;es cient&#237;ficas do Brasil para assegurar uma distribui&#231;&#227;o ideal da pesquisa <italic>online</italic> , considerando o m&#233;todo de amostragem n&#227;o probabil&#237;stica, &#233; poss&#237;vel que nem todos os PRCs no Brasil tenha recebido a pesquisa via <italic>Internet</italic> e, consequentemente, tenham sido sub-representados. No entanto, nosso estudo teve a maior amostra de PRCs do Brasil, fornecendo dados importantes de per&#237;odos anteriores e posteriores &#224; pandemia da COVID-19 que ajudam a guiar PRCs no futuro. Contudo, &#233; necess&#225;rio um registro nacional e multiprofissional para facilitar a comunica&#231;&#227;o e compartilhar experi&#234;ncias entre os PRCs no pa&#237;s.</p>
        <p>A interpreta&#231;&#227;o de estudos baseados na <italic>Internet</italic> pode ser desafiadora. Embora as quest&#245;es tenham sido desenvolvidas e cuidadosamente testadas por profissionais com ampla experi&#234;ncia na &#225;rea de RC e manejo de PRCs, uma ou mais quest&#245;es da pesquisa pode ter sido mal interpretada.</p>
        <p>Os participantes foram solicitados a responder cada quest&#227;o para prosseguirem para se&#231;&#245;es subsequentes da pesquisa online; caso contr&#225;rio, n&#227;o era poss&#237;vel acessar o formul&#225;rio inteiro. Ainda, o participante podia levar o tempo que julgasse necess&#225;rio para responder cada quest&#227;o, uma vez que nosso formul&#225;rio n&#227;o requeria um tempo m&#225;ximo ou m&#237;nimo para isso.</p>
        <p>Finalmente, em rela&#231;&#227;o &#224; poss&#237;vel subestima&#231;&#227;o das taxas de COVID-19, a aus&#234;ncia de suprimentos no in&#237;cio da pandemia no Brasil pode ter contribu&#237;do para uma menor notifica&#231;&#227;o de casos, especialmente em regi&#245;es de baixa renda. No entanto, n&#243;s utilizamos dados de entidades oficiais brasileiras, e essa condi&#231;&#227;o ocorreu em outras partes do mundo no in&#237;cio da pandemia.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclus&#227;o</title>
      <p>Apesar da necessidade de PRCs no Brasil, o n&#250;mero de programas continua significativamente baixo em vista da demanda nacional e local. A pandemia da COVID-19 teve um efeito desfavor&#225;vel sobre os PRCs, diminuindo o n&#250;mero de sess&#245;es de RC dispon&#237;veis no pa&#237;s, apesar de encorajar atividades de telerreabilita&#231;&#227;o durante os dois primeiros meses da pandemia da COVID-19. Uma porcentagem substancial de profissionais da sa&#250;de atuantes em PRCs n&#227;o consideraram seguro realizar RC em pacientes com COVID-19 e n&#227;o estavam preparados para supervisionar os programas no local. Estudos nacionais e multic&#234;ntricos analisando PRCs em diferentes est&#225;gios da pandemia da COVID-19 s&#227;o necess&#225;rios para avaliar seu impacto e compartilhar estrat&#233;gias de sucesso a fim de mitigar os impactos negativos da pandemia sobre esses programas em todo o mundo.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>Refer&#234;ncias</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The Continuing 2019-Ncov Epidemic Threat of Novel Coronaviruses to Global Health - the Latest 2019 Novel Coronavirus Outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264-6. doi: 10.1016/j.ijid.2020.01.009.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hui</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>I Azhar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Madani</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Ntoumi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kock</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dar</surname>
              <given-names>O</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The Continuing 2019-Ncov Epidemic Threat of Novel Coronaviruses to Global Health - the Latest 2019 Novel Coronavirus Outbreak in Wuhan, China</article-title>
          <source>Int J Infect Dis</source>
          <year>2020</year>
          <volume>91</volume>
          <fpage>264</fpage>
          <lpage>266</lpage>
          <issue-id pub-id-type="doi">10.1016/j.ijid.2020.01.009</issue-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Yang P, Wang X. COVID-19: A New Challenge for Human Beings. Cell Mol Immunol. 2020;17(5):555-7. doi: 10.1038/s41423-020-0407-x.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>COVID-19: A New Challenge for Human Beings</article-title>
          <source>Cell Mol Immunol</source>
          <year>2020</year>
          <volume>17</volume>
          <issue>5</issue>
          <fpage>555</fpage>
          <lpage>557</lpage>
          <issue-id pub-id-type="doi">10.1038/s41423-020-0407-x</issue-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, et al. Therapeutic Management of Patients with COVID-19: A Systematic Review. Infect Prev Pract. 2020;2(3):100061. doi: 10.1016/j.infpip.2020.100061.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tobaiqy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Qashqary</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Al-Dahery</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mujallad</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hershan</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Kamal</surname>
              <given-names>MA</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Therapeutic Management of Patients with COVID-19: A Systematic Review</article-title>
          <source>Infect Prev Pract</source>
          <year>2020</year>
          <volume>2</volume>
          <issue>3</issue>
          <size units="pages">100061</size>
          <issue-id pub-id-type="doi">10.1016/j.infpip.2020.100061</issue-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Boldrini P, Bernetti A, Fiore P; SIMFER Executive Committee, SIMFER Committee for International Affairs. Impact of COVID-19 Outbreak on Rehabilitation Services and Physical and Rehabilitation Medicine Physicians&#8217; Activities in Italy. an Official Document of the Italian PRM Society (SIMFER). Eur J Phys Rehabil Med. 2020;56(3):316-8. doi: 10.23736/S1973-9087.20.06256-5.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boldrini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bernetti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fiore</surname>
              <given-names>P</given-names>
            </name>
            <collab>SIMFER Executive Committee</collab>
            <collab>SIMFER Committee for International Affairs</collab>
          </person-group>
          <article-title>Impact of COVID-19 Outbreak on Rehabilitation Services and Physical and Rehabilitation Medicine Physicians&#8217; Activities in Italy. an Official Document of the Italian PRM Society (SIMFER)</article-title>
          <source>Eur J Phys Rehabil Med</source>
          <year>2020</year>
          <volume>56</volume>
          <issue>3</issue>
          <fpage>316</fpage>
          <lpage>318</lpage>
          <issue-id pub-id-type="doi">10.23736/S1973-9087.20.06256-5</issue-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Fiesco-Sep&#250;lveda KY, Serrano-Berm&#250;dez LM. Contributions of Latin American Researchers in the Understanding of the Novel Coronavirus Outbreak: A Literature Review. PeerJ. 2020;8:e9332. doi: 10.7717/peerj.9332.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fiesco-Sep&#250;lveda</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Serrano-Berm&#250;dez</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Contributions of Latin American Researchers in the Understanding of the Novel Coronavirus Outbreak: A Literature Review</article-title>
          <source>PeerJ</source>
          <year>2020</year>
          <volume>8</volume>
          <elocation-id>e9332</elocation-id>
          <issue-id pub-id-type="doi">10.7717/peerj.9332</issue-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Distrito Federal (Brasil). Di&#225;rio Oficial do Distrito Federal [Internet]. Bras&#237;lia: Governo do Distrito Federal; 2020 [[cited 2023 Jan 23]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.buriti.df.gov.br/ftp/diariooficial/2020/03_Mar%C3%A7o/DODF%20028%2014-03-2020%20EDICAO%20EXTRA/DODF%20028%2014-03-2020%20EDICAO%20EXTRA.pdf">http://www.buriti.df.gov.br/ftp/diariooficial/2020/03_Mar%C3%A7o/DODF%20028%2014-03-2020%20EDICAO%20EXTRA/DODF%20028%2014-03-2020%20EDICAO%20EXTRA.pdf</ext-link> </mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Distrito Federal (Brasil)</collab>
          </person-group>
          <source>Di&#225;rio Oficial do Distrito Federal</source>
          <comment>Internet</comment>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Governo do Distrito Federal</publisher-name>
          <year>2020</year>
          <date-in-citation content-type="cited-date">cited 2023 Jan 23</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.buriti.df.gov.br/ftp/diariooficial/2020/03_Mar%C3%A7o/DODF%20028%2014-03-2020%20EDICAO%20EXTRA/DODF%20028%2014-03-2020%20EDICAO%20EXTRA.pdf">http://www.buriti.df.gov.br/ftp/diariooficial/2020/03_Mar%C3%A7o/DODF%20028%2014-03-2020%20EDICAO%20EXTRA/DODF%20028%2014-03-2020%20EDICAO%20EXTRA.pdf</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Distrito Federal (Brasil). Di&#225;rio Oficial do Distrito Federal [Internet]. Bras&#237;lia: Governo do Distrito Federal; 2021 [cited 2023 Jan 23]. Available from: <ext-link ext-link-type="uri" xlink:href="https://dodf.df.gov.br/index/visualizar-arquivo/?pasta=2021%7C03_Mar%C3%A7o%7CDODF%20022%2019-03-2021%20EDICAO%20EXTRA%20A%7C&amp;arquivo=DODF%20022%2019-03-2021%20EDICAO%20EXTRA%20A.pdf">https://dodf.df.gov.br/index/visualizar-arquivo/?pasta=2021%7C03_Mar%C3%A7o%7CDODF%20022%2019-03-2021%20EDICAO%20EXTRA%20A%7C&amp;arquivo=DODF%20022%2019-03-2021%20EDICAO%20EXTRA%20A.pdf</ext-link> </mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Distrito Federal (Brasil)</collab>
          </person-group>
          <source>Di&#225;rio Oficial do Distrito Federal</source>
          <comment>Internet</comment>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Governo do Distrito Federal</publisher-name>
          <year>2021</year>
          <date-in-citation content-type="cited-date">cited 2023 Jan 23</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="https://dodf.df.gov.br/index/visualizar-arquivo/?pasta=2021%7C03_Mar%C3%A7o%7CDODF%20022%2019-03-2021%20EDICAO%20EXTRA%20A%7C&amp;arquivo=DODF%20022%2019-03-2021%20EDICAO%20EXTRA%20A.pdf">https://dodf.df.gov.br/index/visualizar-arquivo/?pasta=2021%7C03_Mar%C3%A7o%7CDODF%20022%2019-03-2021%20EDICAO%20EXTRA%20A%7C&amp;arquivo=DODF%20022%2019-03-2021%20EDICAO%20EXTRA%20A.pdf</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, et al. Advances in the Relationship Between Coronavirus Infection and Cardiovascular Diseases. Biomed Pharmacother. 2020;127:110230. doi: 10.1016/j.biopha.2020.110230.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Advances in the Relationship Between Coronavirus Infection and Cardiovascular Diseases</article-title>
          <source>Biomed Pharmacother</source>
          <year>2020</year>
          <volume>127</volume>
          <size units="pages">110230</size>
          <issue-id pub-id-type="doi">10.1016/j.biopha.2020.110230</issue-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020;382(26):2582. doi: 10.1056/NEJMc2021225.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mehra</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Kuy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Henry</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19</article-title>
          <source>N Engl J Med</source>
          <year>2020</year>
          <volume>382</volume>
          <issue>26</issue>
          <size units="pages">2582</size>
          <issue-id pub-id-type="doi">10.1056/NEJMc2021225</issue-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020;5(7):831-40. doi: 10.1001/jamacardio.2020.1286.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Madjid</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Safavi-Naeini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Solomon</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Vardeny</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Potential Effects of Coronaviruses on the Cardiovascular System: A Review</article-title>
          <source>JAMA Cardiol</source>
          <year>2020</year>
          <volume>5</volume>
          <issue>7</issue>
          <fpage>831</fpage>
          <lpage>840</lpage>
          <issue-id pub-id-type="doi">10.1001/jamacardio.2020.1286</issue-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, et al. Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update: A Scientific Statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2007;115(20):2675-82. doi: 10.1161/CIRCULATIONAHA.106.180945.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balady</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ades</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Bittner</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Comoss</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Foody</surname>
              <given-names>JM</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update: A Scientific Statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation</article-title>
          <source>Circulation</source>
          <year>2007</year>
          <volume>115</volume>
          <issue>20</issue>
          <fpage>2675</fpage>
          <lpage>2682</lpage>
          <issue-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.180945</issue-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. Piepoli MF, Corr&#224; U, Adamopoulos S, Benzer W, Bjarnason-Wehrens B, Cupples M, et al. Secondary Prevention in the Clinical Management of Patients with Cardiovascular Diseases. Core Components, Standards and Outcome Measures for Referral and Delivery: A Policy Statement from the Cardiac Rehabilitation Section of the European Association for Cardiovascular Prevention &amp; Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol. 2014;21(6):664-81. doi: 10.1177/2047487312449597.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piepoli</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Corr&#224;</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Adamopoulos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Benzer</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bjarnason-Wehrens</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cupples</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Secondary Prevention in the Clinical Management of Patients with Cardiovascular Diseases. Core Components, Standards and Outcome Measures for Referral and Delivery: A Policy Statement from the Cardiac Rehabilitation Section of the European Association for Cardiovascular Prevention &amp; Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology</article-title>
          <source>Eur J Prev Cardiol</source>
          <year>2014</year>
          <volume>21</volume>
          <issue>6</issue>
          <fpage>664</fpage>
          <lpage>681</lpage>
          <issue-id pub-id-type="doi">10.1177/2047487312449597.</issue-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13. Kuehn BM. Pandemic Intensifies Push for Home-Based Cardiac Rehabilitation Options. Circulation. 2020;142(18):1781-2. doi: 10.1161/CIRCULATIONAHA.120.051769.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuehn</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Pandemic Intensifies Push for Home-Based Cardiac Rehabilitation Options</article-title>
          <source>Circulation</source>
          <year>2020</year>
          <volume>142</volume>
          <issue>18</issue>
          <fpage>1781</fpage>
          <lpage>1782</lpage>
          <issue-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.051769</issue-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. Ades PA, Keteyian SJ, Wright JS, Hamm LF, Lui K, Newlin K, et al. Increasing Cardiac Rehabilitation Participation from 20% to 70%: A Road Map from the Million Hearts Cardiac Rehabilitation Collaborative. Mayo Clin Proc. 2017;92(2):234-242. doi: 10.1016/j.mayocp.2016.10.014.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ades</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Keteyian</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Hamm</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Lui</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Newlin</surname>
              <given-names>K</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Increasing Cardiac Rehabilitation Participation from 20% to 70%: A Road Map from the Million Hearts Cardiac Rehabilitation Collaborative</article-title>
          <source>Mayo Clin Proc</source>
          <year>2017</year>
          <volume>92</volume>
          <issue>2</issue>
          <fpage>234</fpage>
          <lpage>242</lpage>
          <issue-id pub-id-type="doi">10.1016/j.mayocp.2016.10.014</issue-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15. Piepoli MF, Corr&#224; U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary Prevention Through Cardiac Rehabilitation: From Knowledge to Implementation. A Position Paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(1):1-17. doi: 10.1097/HJR.0b013e3283313592.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piepoli</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Corr&#224;</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Benzer</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bjarnason-Wehrens</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dendale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gaita</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Secondary Prevention Through Cardiac Rehabilitation: From Knowledge to Implementation. A Position Paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation</article-title>
          <source>Eur J Cardiovasc Prev Rehabil</source>
          <year>2010</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>17</lpage>
          <issue-id pub-id-type="doi">10.1097/HJR.0b013e3283313592</issue-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation>16. International Council of Cardiovascular Prevention and Rehabilitation [Internet]. Markham: International Council of Cardiovascular Prevention and Rehabilitation; 2022 [cited 2023 Jan 23]. Available from: <ext-link ext-link-type="uri" xlink:href="https://globalcardiacrehab.com/">https://globalcardiacrehab.com/</ext-link>.</mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>International Council of Cardiovascular Prevention and Rehabilitation</collab>
          </person-group>
          <source>Internet</source>
          <publisher-loc>Markham</publisher-loc>
          <publisher-name>International Council of Cardiovascular Prevention and Rehabilitation</publisher-name>
          <year>2022</year>
          <date-in-citation content-type="cited-date">cited 2023 Jan 23</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="https://globalcardiacrehab.com/">https://globalcardiacrehab.com/</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation>17. Britto RR, Supervia M, Turk-Adawi K, Chaves GSDS, Pesah E, Lopez-Jimenez F, et al. Cardiac Rehabilitation Availability and Delivery in Brazil: A Comparison to Other Upper Middle-Income Countries. Braz J Phys Ther. 2020;24(2):167-176. doi: 10.1016/j.bjpt.2019.02.011.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Britto</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Supervia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Turk-Adawi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chaves</surname>
              <given-names>GSDS</given-names>
            </name>
            <name>
              <surname>Pesah</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lopez-Jimenez</surname>
              <given-names>F</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Cardiac Rehabilitation Availability and Delivery in Brazil: A Comparison to Other Upper Middle-Income Countries</article-title>
          <source>Braz J Phys Ther</source>
          <year>2020</year>
          <volume>24</volume>
          <issue>2</issue>
          <fpage>167</fpage>
          <lpage>176</lpage>
          <issue-id pub-id-type="doi">10.1016/j.bjpt.2019.02.011</issue-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation>18. Brasil. Minist&#233;rio da Sa&#250;de. Sistema de Informa&#231;&#227;o Hospitalar Descentralizado [Internet]. Bras&#237;lia: Minist&#233;rio de Sa&#250;de; 2022 [cited 2023 Jan 23]. Available from: <ext-link ext-link-type="uri" xlink:href="http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/nruf.def">http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/nruf.def</ext-link> </mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Sistema de Informa&#231;&#227;o Hospitalar Descentralizado</source>
          <comment>Internet</comment>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Minist&#233;rio de Sa&#250;de</publisher-name>
          <year>2022</year>
          <date-in-citation content-type="cited-date">cited 2023 Jan 23</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/nruf.def">http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/nruf.def</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation>19. Brasil. Minist&#233;rio da Sa&#250;de. Coronav&#237;rus Brasil. [Internet]. Bras&#237;lia: Minist&#233;rio de Sa&#250;de; 2022 [cited 2023 Jan 23]. Available from: <ext-link ext-link-type="uri" xlink:href="https://covid.saude.gov.br/">https://covid.saude.gov.br/</ext-link> </mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Minist&#233;rio da Sa&#250;de</collab>
          </person-group>
          <source>Coronav&#237;rus Brasil</source>
          <comment>Internet</comment>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Minist&#233;rio de Sa&#250;de</publisher-name>
          <year>2022</year>
          <date-in-citation content-type="cited-date">cited 2023 Jan 23</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="https://covid.saude.gov.br/">https://covid.saude.gov.br/</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation>20. Instituto Brasileiro de Geografia e Estat&#237;stica [Internet]. Rio de Janeiro: Instituto Brasileiro de Geografia e Estat&#237;stica; 2022 [cited 2023 Jan 23]. Available from: <ext-link ext-link-type="uri" xlink:href="ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2020/estimativa_dou_2020.xls">ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2020/estimativa_dou_2020.xls</ext-link> </mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Instituto Brasileiro de Geografia e Estat&#237;stica</collab>
          </person-group>
          <source>Internet</source>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <publisher-name>Instituto Brasileiro de Geografia e Estat&#237;stica</publisher-name>
          <year>2022</year>
          <date-in-citation content-type="cited-date">cited 2023 Jan 23</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2020/estimativa_dou_2020.xls">ftp://ftp.ibge.gov.br/Estimativas_de_Populacao/Estimativas_2020/estimativa_dou_2020.xls</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation>21. Instituto de Pesquisa Econ&#244;mica Aplicada. Desenvolvimento Humano nas Macrorregi&#245;es Brasileiras [Internet]. Bras&#237;lia: Instituto de Pesquisa Econ&#244;mica Aplicada; 2022 [cited 2023 Jan 23]. Available from: <ext-link ext-link-type="uri" xlink:href="http://repositorio.ipea.gov.br/bitstream/11058/6217/1/Desenvolvimento%20humano%20nas%20macrorregi%C3%B5es%20brasileiras.pdf">http://repositorio.ipea.gov.br/bitstream/11058/6217/1/Desenvolvimento%20humano%20nas%20macrorregi%C3%B5es%20brasileiras.pdf</ext-link> </mixed-citation>
        <element-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>Instituto de Pesquisa Econ&#244;mica Aplicada</collab>
          </person-group>
          <source>Desenvolvimento Humano nas Macrorregi&#245;es Brasileiras</source>
          <comment>Internet</comment>
          <publisher-loc>Bras&#237;lia</publisher-loc>
          <publisher-name>Instituto de Pesquisa Econ&#244;mica Aplicada</publisher-name>
          <year>2022</year>
          <date-in-citation content-type="cited-date">cited 2023 Jan 23</date-in-citation>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://repositorio.ipea.gov.br/bitstream/11058/6217/1/Desenvolvimento%20humano%20nas%20macrorregi%C3%B5es%20brasileiras.pdf">http://repositorio.ipea.gov.br/bitstream/11058/6217/1/Desenvolvimento%20humano%20nas%20macrorregi%C3%B5es%20brasileiras.pdf</ext-link>
          </comment>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation>22. Taylor RS, Walker S, Smart NA, Piepoli MF, Warren FC, Ciani O, et al. Impact of Exercise-Based Cardiac Rehabilitation in Patients with Heart Failure (Extramatch II) On Mortality and Hospitalisation: An Individual Patient Data Meta-Analysis of Randomised Trials. Eur J Heart Fail. 2018;20(12):1735-43. doi: 10.1002/ejhf.1311.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Smart</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Piepoli</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Ciani</surname>
              <given-names>O</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Impact of Exercise-Based Cardiac Rehabilitation in Patients with Heart Failure (Extramatch II) On Mortality and Hospitalisation: An Individual Patient Data Meta-Analysis of Randomised Trials</article-title>
          <source>Eur J Heart Fail</source>
          <year>2018</year>
          <volume>20</volume>
          <issue>12</issue>
          <fpage>1735</fpage>
          <lpage>1743</lpage>
          <issue-id pub-id-type="doi">10.1002/ejhf.1311</issue-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation>23. Turk-Adawi KI, Terzic C, Bjarnason-Wehrens B, Grace SL. Cardiac Rehabilitation in Canada and Arab Countries: Comparing Availability and Program Characteristics. BMC Health Serv Res. 2015;15:521. doi: 10.1186/s12913-015-1183-7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turk-Adawi</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Terzic</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bjarnason-Wehrens</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Grace</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Cardiac Rehabilitation in Canada and Arab Countries: Comparing Availability and Program Characteristics</article-title>
          <source>BMC Health Serv Res</source>
          <year>2015</year>
          <volume>15</volume>
          <size units="pages">521</size>
          <issue-id pub-id-type="doi">10.1186/s12913-015-1183-7</issue-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation>24. Boldrini P, Bernetti A, Fiore P; SIMFER Executive Committee, SIMFER Committee for International Affairs. Impact of COVID-19 Outbreak on Rehabilitation Services and Physical and Rehabilitation Medicine Physicians&#8217; Activities in Italy. an Official Document of the Italian PRM Society (SIMFER). Eur J Phys Rehabil Med. 2020;56(3):316-8. doi: 10.23736/S1973-9087.20.06256-5.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boldrini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bernetti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fiore</surname>
              <given-names>P</given-names>
            </name>
            <collab>SIMFER Executive Committee</collab>
            <collab>SIMFER Committee for International Affairs</collab>
          </person-group>
          <article-title>Impact of COVID-19 Outbreak on Rehabilitation Services and Physical and Rehabilitation Medicine Physicians&#8217; Activities in Italy. an Official Document of the Italian PRM Society (SIMFER)</article-title>
          <source>Eur J Phys Rehabil Med</source>
          <year>2020</year>
          <volume>56</volume>
          <issue>3</issue>
          <fpage>316</fpage>
          <lpage>318</lpage>
          <issue-id pub-id-type="doi">10.23736/S1973-9087.20.06256-5</issue-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation>25. Scherrenberg M, Wilhelm M, Hansen D, V&#246;ller H, Cornelissen V, Frederix I, et al. The Future is Now: A Call for Action for Cardiac Telerehabilitation in the COVID-19 Pandemic from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020;2047487320939671. doi: 10.1177/2047487320939671.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scherrenberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wilhelm</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>V&#246;ller</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cornelissen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Frederix</surname>
              <given-names>I</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The Future is Now: A Call for Action for Cardiac Telerehabilitation in the COVID-19 Pandemic from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology</article-title>
          <source>Eur J Prev Cardiol</source>
          <year>2020</year>
          <comment>2047487320939671</comment>
          <issue-id pub-id-type="doi">10.1177/2047487320939671</issue-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation>26. Carvalho T, Milani M, Ferraz AS, Silveira AD, Herdy AH, Hossri CAC, et al. Diretriz Brasileira de Reabilita&#231;&#227;o Cardiovascular &#8211; 2020. Arq Bras Cardiol. 2020;114(5):943-87. doi: 10.36660/abc.20200407.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carvalho</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Milani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ferraz</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Silveira</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Herdy</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Hossri</surname>
              <given-names>CAC</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Diretriz Brasileira de Reabilita&#231;&#227;o Cardiovascular &#8211; 2020</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <volume>114</volume>
          <issue>5</issue>
          <fpage>943</fpage>
          <lpage>987</lpage>
          <issue-id pub-id-type="doi">10.36660/abc.20200407</issue-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation>27. Frederix I, Vanhees L, Dendale P, Goetschalckx K. A Review of Telerehabilitation for Cardiac Patients. J Telemed Telecare. 2015;21(1):45-53. doi: 10.1177/1357633X14562732.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frederix</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Vanhees</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dendale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Goetschalckx</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A Review of Telerehabilitation for Cardiac Patients</article-title>
          <source>J Telemed Telecare</source>
          <year>2015</year>
          <volume>21</volume>
          <issue>1</issue>
          <fpage>45</fpage>
          <lpage>53</lpage>
          <issue-id pub-id-type="doi">10.1177/1357633X14562732</issue-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation>28. Thomas RJ, Huang HH. Cardiac Rehabilitation for Secondary Prevention of Cardiovascular Disease: 2019 Update. Curr Treat Options Cardiovasc Med. 2019;21(10):56. doi: 10.1007/s11936-019-0759-7.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Cardiac Rehabilitation for Secondary Prevention of Cardiovascular Disease: 2019 Update</article-title>
          <source>Curr Treat Options Cardiovasc Med</source>
          <year>2019</year>
          <volume>21</volume>
          <issue>10</issue>
          <size units="pages">56</size>
          <issue-id pub-id-type="doi">10.1007/s11936-019-0759-7</issue-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation>29. Anderson L, Sharp GA, Norton RJ, Dalal H, Dean SG, Jolly K, et al. Home-Based Versus Centre-Based Cardiac Rehabilitation. Cochrane Database Syst Rev. 2017;6(6):CD007130. doi: 10.1002/14651858.CD007130.pub4.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sharp</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Norton</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Dalal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Jolly</surname>
              <given-names>K</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Home-Based Versus Centre-Based Cardiac Rehabilitation</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2017</year>
          <volume>6</volume>
          <issue>6</issue>
          <comment>CD007130</comment>
          <issue-id pub-id-type="doi">10.1002/14651858.CD007130.pub4</issue-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation>30. Xu L, Li F, Zhou C, Li J, Hong C, Tong Q. The Effect of Mobile Applications for Improving Adherence in Cardiac Rehabilitation: A Systematic Review and Meta-Analysis. BMC Cardiovasc Disord. 2019;19(1):166. doi: 10.1186/s12872-019-1149-5.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>The Effect of Mobile Applications for Improving Adherence in Cardiac Rehabilitation: A Systematic Review and Meta-Analysis</article-title>
          <source>BMC Cardiovasc Disord</source>
          <year>2019</year>
          <volume>19</volume>
          <issue>1</issue>
          <size units="pages">166</size>
          <issue-id pub-id-type="doi">10.1186/s12872-019-1149-5</issue-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation>31. Walton M, Murray E, Christian MD. Mental Health Care for Medical Staff and Affiliated Healthcare Workers During the COVID-19 Pandemic. Eur Heart J Acute Cardiovasc Care. 2020;9(3):241-247. doi: 10.1177/2048872620922795.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walton</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Christian</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Mental Health Care for Medical Staff and Affiliated Healthcare Workers During the COVID-19 Pandemic</article-title>
          <source>Eur Heart J Acute Cardiovasc Care</source>
          <year>2020</year>
          <volume>9</volume>
          <issue>3</issue>
          <fpage>241</fpage>
          <lpage>247</lpage>
          <issue-id pub-id-type="doi">10.1177/2048872620922795</issue-id>
        </element-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="other">
        <p>Vincula&#231;&#227;o acad&#234;mica</p>
        <p>Este artigo &#233; parte de disserta&#231;&#227;o de mestrado de Iara Sousa Cez&#225;rio Jardim pela Universidade de Bras&#237;lia.</p>
      </fn>
    </fn-group>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Fontes de financiamento: O presente estudo n&#227;o teve fontes de financiamento externas.</p>
      </fn>
    </fn-group>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Impact of COVID-19&#8217;s on Cardiovascular Rehabilitation Programs in Brazil: An Online Survey-Based Cross-Sectional Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-7651-699X</contrib-id>
          <name>
            <surname>Jardim</surname>
            <given-names>Iara de Sousa Cez&#225;rio</given-names>
          </name>
          <role>Conception and design of the research and Critical revision of the manuscript for important intellectual content</role>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis</role>
          <role>Writing of the manuscript</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-3688-2108</contrib-id>
          <name>
            <surname>Milani</surname>
            <given-names>Mauricio</given-names>
          </name>
          <role>Conception and design of the research and Critical revision of the manuscript for important intellectual content</role>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis</role>
          <role>Writing of the manuscript</role>
          <xref ref-type="aff" rid="aff2001">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3001">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castro</surname>
            <given-names>Isac</given-names>
          </name>
          <role>Conception and design of the research and Critical revision of the manuscript for important intellectual content</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis</role>
          <xref ref-type="aff" rid="aff4001">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hansen</surname>
            <given-names>Dominique</given-names>
          </name>
          <role>Conception and design of the research and Critical revision of the manuscript for important intellectual content</role>
          <xref ref-type="aff" rid="aff5001">
            <sup>5</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-2476-7981</contrib-id>
          <name>
            <surname>Karsten</surname>
            <given-names>Marlus</given-names>
          </name>
          <role>Conception and design of the research and Critical revision of the manuscript for important intellectual content</role>
          <xref ref-type="aff" rid="aff6001">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cahalin</surname>
            <given-names>Lawrence Patrick</given-names>
          </name>
          <role>Conception and design of the research and Critical revision of the manuscript for important intellectual content</role>
          <xref ref-type="aff" rid="aff7001">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cipriano</surname>
            <given-names>Graziella Fran&#231;a Bernardelli</given-names>
          </name>
          <role>Conception and design of the research and Critical revision of the manuscript for important intellectual content</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-6323-7003</contrib-id>
          <name>
            <surname>Cipriano</surname>
            <given-names>Gerson</given-names>
            <suffix>Jr</suffix>
          </name>
          <role>Conception and design of the research and Critical revision of the manuscript for important intellectual content</role>
          <role>Acquisition of data</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis</role>
          <role>Writing of the manuscript</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1001">
        <label>1</label>
        <country country="BR">Brasil</country>
        <institution content-type="original">Programa de P&#243;s Gradua&#231;&#227;o em Ci&#234;ncias da Reabilita&#231;&#227;o (PPGCR), Universidade de Bras&#237;lia (UNB), Bras&#237;lia, DF &#8211; Brasil</institution>
      </aff>
      <aff id="aff2001">
        <label>2</label>
        <country country="BR">Brasil</country>
        <institution content-type="original">Fitcordis, Bras&#237;lia, DF &#8211; Brasil</institution>
      </aff>
      <aff id="aff3001">
        <label>3</label>
        <country country="BR">Brasil</country>
        <institution content-type="original">Programa de P&#243;s Gradua&#231;&#227;o em Ci&#234;ncias e Tecnologias em Sa&#250;de (PPGCTS), Universidade de Bras&#237;lia (UNB), Bras&#237;lia, DF &#8211; Brasil</institution>
      </aff>
      <aff id="aff4001">
        <label>4</label>
        <country country="BR">Brasil</country>
        <institution content-type="original">Universidade de S&#227;o Paulo, S&#227;o Paulo, SP &#8211; Brasil</institution>
      </aff>
      <aff id="aff5001">
        <label>5</label>
        <country country="BE">B&#233;lgica</country>
        <institution content-type="original">Hasselt University, Hasselt &#8211; B&#233;lgica</institution>
      </aff>
      <aff id="aff6001">
        <label>6</label>
        <country country="BR">Brasil</country>
        <institution content-type="original">Programa de P&#243;s-gradua&#231;&#227;o em Fisioterapia (PPGFT), Universidade do Estado de Santa Catarina, Florian&#243;polis, SC &#8211; Brasil</institution>
      </aff>
      <aff id="aff7001">
        <label>7</label>
        <country country="US">EUA</country>
        <institution content-type="original">Miller School of Medicine, Miami, Fl&#243;rida &#8211; EUA</institution>
      </aff>
      <author-notes>
        <corresp id="c01001">Mailing Address: Iara de Sousa Cez&#225;rio Jardim &#8226; Universidade de Bras&#237;lia &#8211; ci&#234;ncias da reabilita&#231;&#227;o &#8211; Campus Universit&#225;rio, s/n. Postal Code 70910-900, Centro Metropolitano, Bras&#237;lia, DF &#8211; Brazil E-mail: iaracezario@gmail.com</corresp>
        <fn fn-type="conflict">
          <p>Potential conflict of interest</p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <abstract>
        <title>Abstract</title>
        <sec>
          <title>Background</title>
          <p>The COVID-19 pandemic had an impact on cardiovascular rehabilitation (CR) programs in Brazil.</p>
        </sec>
        <sec>
          <title>Objectives</title>
          <p>To describe the characteristics of CR programs in Brazil, the impacts of the first epidemiological wave of COVID-19 (first 60 days) on the programs and present the initiatives used to overcome the impacts.</p>
        </sec>
        <sec>
          <title>Method</title>
          <p>This cross-sectional and retrospective study utilized a specific online survey. Participants were coordinators of CR programs. Variables were presented by Brazilian geographic region and as the following categories: demographic, clinical and operational characteristics. The significance level for statistical analysis was set at 5%.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Fifty-nine CR programs were responsible for 5,349 patients, of which only 1,817 were post-acute cardiovascular events, which corresponded to 1.99% of hospitalized patients in the month prior to the survey (n=91,231). The greatest impact was the suspension of on-site activities, which occurred similarly in areas with the highest and the lowest rates of COVID-19 in the period. Forty-five programs (75%) were shortly interrupted, while three (5%) were ended. All 42 programs that already used remote rehabilitation strategies noticed a substantial increase in activities, based primarily on the use of media and video calling. Only three (5%) considered safe to see patients during the first 60 days.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>There was a reduction in the number of CR programs with the COVID-19 pandemic. Telerehabilitation activities increased during the first two months of the COVID-19 pandemic, but this was not enough to overcome the reduction in CR program activities across Brazil.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>COVID-19</kwd>
        <kwd>Telerehabilitation</kwd>
        <kwd>Research</kwd>
        <kwd>Surveys and Questionnaires</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec sec-type="intro">
        <title>Introduction</title>
        <p>On March 11, 2020, a worldwide pandemic was declared due to the emergence of COVID-19 (abbreviation for CoronaVirus Disease 2019).<sup><xref ref-type="bibr" rid="B1">1</xref></sup> There were no specific pharmaceutical products or regulated vaccines to treat the disease caused by SARS-CoV-2 during the first half of 2020.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> Preventative measures to reduce the rapid spread of this respiratory virus, including social distancing, were therefore recommended worldwide.<sup><xref ref-type="bibr" rid="B3">3</xref></sup> The recommendation by health agencies to reduce physical contact increased the restrictions to many public and private areas, including healthcare services.<sup><xref ref-type="bibr" rid="B4">4</xref></sup> This phenomenon also occurred in Brazil, where the first case was reported on February 25, 2020, nine weeks after the first reported case in China.<sup><xref ref-type="bibr" rid="B5">5</xref></sup> In Brazil&#8217;s capital, Bras&#237;lia, for example, the government issued its first decree for the closure of several establishments on March 11, 2020 (in the 11th epidemiological week),<sup><xref ref-type="bibr" rid="B6">6</xref></sup> and these recommendations continued to change throughout the year with alterations of the restrictions still being announced in the first months of 2021.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
        <p>According to recent publications, chronic conditions, including pulmonary and cardiovascular diseases, diabetes mellitus, and hypertension, have been associated with more severe manifestations of COVID-19 infection and a poorer prognosis.<sup><xref ref-type="bibr" rid="B8">8</xref> , <xref ref-type="bibr" rid="B9">9</xref></sup> Therefore, individuals with these conditions have been called to increase precautionary procedures and keep their clinical treatments updated, thus avoiding contamination, decompensation, and further hospitalizations.<sup><xref ref-type="bibr" rid="B10">10</xref></sup></p>
        <p>Despite being considered a vital component for heart failure treatment,<sup><xref ref-type="bibr" rid="B11">11</xref> , <xref ref-type="bibr" rid="B12">12</xref></sup> the availability and adherence to cardiovascular rehabilitation (CR) were also highly affected due to new restrictions during the pandemic.<sup><xref ref-type="bibr" rid="B13">13</xref></sup> CR is composed of specific core components that aim to stimulate healthy habits, promote an active lifestyle, optimize clinical conditions, and reduce cardiovascular risks,<sup><xref ref-type="bibr" rid="B11">11</xref></sup> as supported by robust evidence of preventing hospitalizations and cost-effectively increasing cardiorespiratory fitness.<sup><xref ref-type="bibr" rid="B14">14</xref> , <xref ref-type="bibr" rid="B15">15</xref></sup></p>
        <p>This study aims to describe the characteristics of cardiac rehabilitation programs (CRPs) in Brazil, in its main geographic regions, before and during the pandemic, verify the impact of the COVID-19 pandemic (60 days after the first confirmed case of COVID-19 in Brazil) and report the main initiatives created to maintain the CRPs in the face of restrictions imposed by public officials.</p>
      </sec>
      <sec sec-type="methods">
        <title>Methods</title>
        <sec>
          <title>Ethical approval and methodological design</title>
          <p>In this cross-sectional and retrospective study, a customized online survey developed by CR healthcare professionals and researchers was used. The ethics committee approved the study (CAAE number 36041220.4.0000.8093). The participants signed a non-disclosure agreement on the scientific purpose and anonymous presentation of their data at an online international scientific meeting &#8211; the International Council of Cardiovascular Prevention and Rehabilitation&#8211;<sup><xref ref-type="bibr" rid="B16">16</xref></sup> and further publication.</p>
        </sec>
        <sec>
          <title>Online survey</title>
          <p>The online survey was developed by two researchers, to present, for the first time in the literature, Brazilian data on the impact of COVID-19 on CR, at an international scientific webinar organized by the International Council of Cardiovascular Prevention and Rehabilitation (ICCPR).<sup><xref ref-type="bibr" rid="B16">16</xref></sup> The complete data collected were recorded for further assessment after approval by the ethics committee.</p>
          <p>A free survey software (Google forms, Google LLC, California, United States) was used to develop both objective and subjective questions of the questionnaire. The questionnaire was distributed between April 20<sup>th</sup>and 30<sup>th</sup>of 2020 (60 days after the first confirmed case of COVID-19 in Brazil). The order of the questions was first aimed at characterizing CR services before the COVID-19 pandemic and, secondly, to present necessary and/or potential adaptations for the novel pandemic scenario. Although there was no time limit for respondents to complete the questionnaire, the approximate time for completing the form was set to be 10 to 15 minutes per participant. Each page had to be answered to fill the questionnaire. The Portuguese version used is still available <italic>online</italic> for consultation (https://forms.gle/hWiKojuAz68FpUeD6)</p>
          <p>CR professionals were also required to agree to the terms of disclosure, consenting for the anonymous presentation of data at the ICCPR webinar and future scientific publications after ethics approval.</p>
        </sec>
        <sec>
          <title>Participants, and inclusion and exclusion criteria</title>
          <p>Study participants were coordinators of CRP selected by non-probabilistic sampling. The link to access the online survey was made available via social networks, and recipients were encouraged to share the invitation with other professionals to reach as many professionals as possible (i.e., &#8220;snowball&#8221; strategy).</p>
          <p>As inclusion criteria, the CRP needed to offer at least one of the eight core components recommended in the literature.<sup><xref ref-type="bibr" rid="B11">11</xref></sup> Duplicate or partially answered questionnaires were excluded from the study.</p>
        </sec>
        <sec>
          <title>Statistical analysis</title>
          <p>The Kolmogorov-Smirnov test verified the adherence of the sample data to the normal distribution. As there was no adherence, the continuous variables were described as median and interquartile range. Categorical data were presented as absolute frequency and percentages. Data were analyzed using the McNemar&#180;s test in a 2x2 table, using: 1) the strategy promoted behavior change; 2) started or stopped using the strategy at two different points &#8211; before and after the pandemic period. Categorical data were compared using the X<sup>2</sup>test. The Kruskal Wallis test was used to compare medians of non-parametric data. We used a p&lt;0.05, and a beta error &#8804; 0.2 for statistical significance. Statistical analyses were performed using SPSS version 23.0 for MacOS.</p>
          <p>A total of 57 CRPs was required in the study (76% of participants), which was calculated using a z score of 1.96 and a margin of error of 6% and considering an estimated 75 programs in Brazil.<sup><xref ref-type="bibr" rid="B17">17</xref></sup> Calculations were done using the StatCal Software, EPIinfo, and the Centers for Disease Control and Prevention (CDC)&#8217;s for population questionnaires. To estimate the demand for CRP in Brazil and in each of its geographic region, we considered the number of hospitalizations for cardiovascular disease in the month prior to the survey &#8211; March 2020,<sup><xref ref-type="bibr" rid="B18">18</xref></sup> (since the number of hospitalizations was similar to the previous 12-month average), divided by the number of CR sessions potentially available for the patients who had a recent acute cardiovascular event (&lt;12 weeks).</p>
          <p>To calculate the average rate of infection of COVID-19 for April 2020 by geographic region, we considered the number of cases registered in the national health system in 2020,<sup><xref ref-type="bibr" rid="B19">19</xref></sup> divided by the number of inhabitants registered by the Brazilian Institute of Geography and Statistics for the same period.<sup><xref ref-type="bibr" rid="B20">20</xref></sup> This ratio was expressed per 100,000 inhabitants.</p>
        </sec>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <sec>
          <title>Characteristics of cardiovascular rehabilitation programs before the COVID-19 pandemic</title>
          <p>The response rate to our questionnaire was 78.66% of the expected number (61 out of 75 programs). Two programs were excluded due to duplicity, resulting in 59 surveys for analysis.</p>
          <p>The characteristics of CRPs before the COVID-19 pandemic were categorized according to the geographic regions of Brazil: north (NO), northeast (NE), mid-west (MW), southeast (SE), and south (SO) ( <xref ref-type="table" rid="t1001">Table 1</xref> ).</p>
          <p>
            <table-wrap id="t1001">
              <label>Table 1</label>
              <caption>
                <title>&#8211; Demographic and clinical characteristics of cardiovascular rehabilitation programs before the first confirmed case of COVID-19 in Brazil and hospitalizations for cardiovascular diseases by Brazilian region</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" colspan="2" rowspan="3">Demographic characteristics</th>
                    <th colspan="5">Brazilian region</th>
                    <th rowspan="3">Total</th>
                    <th rowspan="3">p</th>
                  </tr>
                  <tr>
                    <th colspan="5">
                      <hr/>
                    </th>
                  </tr>
                  <tr>
                    <th>Midwest</th>
                    <th>Northeast</th>
                    <th>South</th>
                    <th>Southeast</th>
                    <th>North</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td rowspan="13">Profile of Service Provided in median (IQR) or n <italic>(%)</italic></td>
                    <td>Time of Existence (month)</td>
                    <td align="center">77 (42 -131)</td>
                    <td align="center">68 (28 - 96)</td>
                    <td align="center">57 (20 - 229)</td>
                    <td align="center">141 (70 - 238)</td>
                    <td align="center">-</td>
                    <td align="center">-</td>
                    <td align="center">0.26</td>
                  </tr>
                  <tr>
                    <td>No. of programs</td>
                    <td align="center">9 (15.25)</td>
                    <td align="center">8 (13.55)</td>
                    <td align="center">12 (20.33)</td>
                    <td align="center">30 (50.84)</td>
                    <td align="center">-</td>
                    <td align="center">59</td>
                    <td align="center">-</td>
                  </tr>
                  <tr>
                    <td>Human Development Index<sup>32</sup></td>
                    <td align="center">0.757</td>
                    <td align="center">0.663</td>
                    <td align="center">0.754</td>
                    <td align="center">0.766</td>
                    <td align="center">0.667</td>
                    <td align="center">-</td>
                    <td align="center">-</td>
                  </tr>
                  <tr>
                    <td>No. of patients per month (per program)</td>
                    <td align="center">50 (20 - 50)</td>
                    <td align="center">18 (7 - 65)</td>
                    <td align="center">25 (7 - 115)</td>
                    <td align="center">78 (49 - 180)</td>
                    <td align="center">-</td>
                    <td align="center" rowspan="2">5,349</td>
                    <td align="center" rowspan="2">0.01</td>
                  </tr>
                  <tr>
                    <td>No. of patients per month</td>
                    <td align="center">428 (8)</td>
                    <td align="center">270 (5.04)</td>
                    <td align="center">985 (18.41)</td>
                    <td align="center">3.711 (69.37)</td>
                    <td align="center">-</td>
                  </tr>
                  <tr>
                    <td>No. of sessions per month (per program)</td>
                    <td align="center">200 (12 - 280)</td>
                    <td align="center">76 (12 - 220)</td>
                    <td align="center">40 (10 - 132)</td>
                    <td align="center">180 (50 - 400)</td>
                    <td align="center">-</td>
                    <td align="center" rowspan="2">32,449</td>
                    <td align="center" rowspan="2">0.25</td>
                  </tr>
                  <tr>
                    <td>No. of sessions per month</td>
                    <td align="center">3,016 (9.29)</td>
                    <td align="center">1,764 (5.43)</td>
                    <td align="center">5,080 (15.65)</td>
                    <td align="center">22,589 (69.61)</td>
                    <td align="center">-</td>
                  </tr>
                  <tr>
                    <td>Percentage of Low-risk patients* per month (per program)</td>
                    <td align="center">30 (20 - 50)</td>
                    <td align="center">15 (5 - 55)</td>
                    <td align="center">30 (10 - 50)</td>
                    <td align="center">25 (20 - 50)</td>
                    <td align="center">-</td>
                    <td align="center">1,407</td>
                    <td align="center">0.54</td>
                  </tr>
                  <tr>
                    <td>Percentage of Moderate risk patients* per month (per program)</td>
                    <td align="center">50 (30 - 60)</td>
                    <td align="center">50 (20 - 65)</td>
                    <td align="center">35 (20 - 50)</td>
                    <td align="center">35(20 - 5)</td>
                    <td align="center">-</td>
                    <td align="center">2,145</td>
                    <td align="center">0.27</td>
                  </tr>
                  <tr>
                    <td>Percentage of High-risk patients* per month (per program) *</td>
                    <td align="center">20 (10 - 20)</td>
                    <td align="center">30 (10 - 50)</td>
                    <td align="center">25 (5 - 55)</td>
                    <td align="center">30 (20 - 50)</td>
                    <td align="center">-</td>
                    <td align="center">2,097</td>
                    <td align="center">0.31</td>
                  </tr>
                  <tr>
                    <td>Percentage of post-acute cardiovascular event patients (&lt;12 weeks) per month (per program)</td>
                    <td align="center">20 (20 - 30)</td>
                    <td align="center">15 (0 - 25)</td>
                    <td align="center">10 (5 - 30)</td>
                    <td align="center">20 (20 - 30)</td>
                    <td align="center">-</td>
                    <td align="center" rowspan="2">1,817</td>
                    <td align="center" rowspan="2">0.30</td>
                  </tr>
                  <tr>
                    <td>No. of post-acute cardiovascular event patients (&lt;12 weeks) per month</td>
                    <td align="center">220 (12.1)</td>
                    <td align="center">557 (30.7)</td>
                    <td align="center">230 (12.7)</td>
                    <td align="center">810 (44.6)</td>
                    <td align="center">-</td>
                  </tr>
                  <tr>
                    <td>CRP patients covered by the public health system (per program)</td>
                    <td align="center">0 (0 - 0)</td>
                    <td align="center">5 (0 - 45)</td>
                    <td align="center">25 (0 - 25)</td>
                    <td align="center">70 (0 - 70)</td>
                    <td align="center">-</td>
                    <td align="center">1,173</td>
                    <td align="center">0.48</td>
                  </tr>
                  <tr>
                    <td colspan="2">Hospitalizations due to CVD in March 2020<sup>29</sup></td>
                    <td align="center">6,778 (7.4)</td>
                    <td align="center">20,127 (22)</td>
                    <td align="center">20,395 (22.3)</td>
                    <td align="center">39,573 (43.3)</td>
                    <td align="center">4,358 (4.7)</td>
                    <td align="center">91,231</td>
                    <td align="center">-</td>
                  </tr>
                  <tr>
                    <td colspan="2">The ratio of post-acute patients in rehabilitation/Hospitalized due to CVD in March 2020 (%)</td>
                    <td align="center">3.24</td>
                    <td align="center">2.76</td>
                    <td align="center">1.12</td>
                    <td align="center">2.04</td>
                    <td align="center">0</td>
                    <td align="center">1.99</td>
                    <td align="center">-</td>
                  </tr>
                  <tr>
                    <td colspan="2" rowspan="3">
                      <bold>Clinical characteristics</bold>
                    </td>
                    <td align="center" colspan="5">
                      <bold>Brazilian region</bold>
                    </td>
                    <td align="center" rowspan="3">
                      <bold>Total</bold>
                    </td>
                    <td align="center" rowspan="3">
                      <bold>p</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" colspan="5">
                      <hr/>
                    </td>
                  </tr>
                  <tr>
                    <td align="center">
                      <bold>Midwest</bold>
                    </td>
                    <td align="center">
                      <bold>Northeast</bold>
                    </td>
                    <td align="center">
                      <bold>South</bold>
                    </td>
                    <td align="center">
                      <bold>Southeast</bold>
                    </td>
                    <td align="center">
                      <bold>North</bold>
                    </td>
                  </tr>
                  <tr>
                    <td rowspan="14">Number (%) of programs directed to specific clinical conditions</td>
                    <td>Heart failure</td>
                    <td align="center">8 (88.9)</td>
                    <td align="center">8 (100)</td>
                    <td align="center">9 (75)</td>
                    <td align="center">30 (100)</td>
                    <td align="center">0</td>
                    <td align="center">55 (98)</td>
                    <td align="center">0.02</td>
                  </tr>
                  <tr>
                    <td>Coronary revascularization</td>
                    <td align="center">8 (88.9)</td>
                    <td align="center">7 (87.5)</td>
                    <td align="center">9 (75)</td>
                    <td align="center">29 (96.7)</td>
                    <td align="center">0</td>
                    <td align="center">53 (89)</td>
                    <td align="center">0.21</td>
                  </tr>
                  <tr>
                    <td>After pacemaker implant and/or ICD</td>
                    <td align="center">6 (66.7)</td>
                    <td align="center">6 (75)</td>
                    <td align="center">7 (58.3)</td>
                    <td align="center">25 (83.3)</td>
                    <td align="center">0</td>
                    <td align="center">44 (74)</td>
                    <td align="center">0.36</td>
                  </tr>
                  <tr>
                    <td>Stable coronaropathy</td>
                    <td align="center">6 (66.7)</td>
                    <td align="center">5 (62.5)</td>
                    <td align="center">6 (500</td>
                    <td align="center">25 (83.3)</td>
                    <td align="center">0</td>
                    <td align="center">42 (71)</td>
                    <td align="center">0.16</td>
                  </tr>
                  <tr>
                    <td>Acute coronary syndrome</td>
                    <td align="center">7 (77.8)</td>
                    <td align="center">5 (62.5)</td>
                    <td align="center">7 (58.3)</td>
                    <td align="center">22 (73.3)</td>
                    <td align="center">0</td>
                    <td align="center">41 (69)</td>
                    <td align="center">0.70</td>
                  </tr>
                  <tr>
                    <td>Metabolic syndrome</td>
                    <td align="center">7 (77.8)</td>
                    <td align="center">5 (62.5)</td>
                    <td align="center">6 (50)</td>
                    <td align="center">23 (76.7)</td>
                    <td align="center">0</td>
                    <td align="center">41 (69)</td>
                    <td align="center">0.34</td>
                  </tr>
                  <tr>
                    <td>Diabetes</td>
                    <td align="center">6 (66.7)</td>
                    <td align="center">4 (50)</td>
                    <td align="center">6 (50)</td>
                    <td align="center">23 (76.7)</td>
                    <td align="center">0</td>
                    <td align="center">39 (66)</td>
                    <td align="center">0.28</td>
                  </tr>
                  <tr>
                    <td>Post-valve surgery</td>
                    <td align="center">5 (55.6)</td>
                    <td align="center">4 (50)</td>
                    <td align="center">5 (41.7)</td>
                    <td align="center">21 (70)</td>
                    <td align="center">0</td>
                    <td align="center">35 (59)</td>
                    <td align="center">0.34</td>
                  </tr>
                  <tr>
                    <td>POAD</td>
                    <td align="center">2 (22.2)</td>
                    <td align="center">3 (37.5)</td>
                    <td align="center">6 (50)</td>
                    <td align="center">18 (60)</td>
                    <td align="center">0</td>
                    <td align="center">30 (50)</td>
                    <td align="center">0.21</td>
                  </tr>
                  <tr>
                    <td>Adult congenital cardiac disease</td>
                    <td align="center">3 (33.3)</td>
                    <td align="center">2 (25)</td>
                    <td align="center">0 (0)</td>
                    <td align="center">11 (36.7)</td>
                    <td align="center">0</td>
                    <td align="center">16 (27)</td>
                    <td align="center">0.11</td>
                  </tr>
                  <tr>
                    <td>Post-cardiac Transplantation or VAD</td>
                    <td align="center">0 (0)</td>
                    <td align="center">2 (25)</td>
                    <td align="center">1 (8.3)</td>
                    <td align="center">13 (43.3)</td>
                    <td align="center">0</td>
                    <td align="center">16 (27)</td>
                    <td align="center">0.02</td>
                  </tr>
                  <tr>
                    <td>Others</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">3 (37.5)</td>
                    <td align="center">2 (16.7)</td>
                    <td align="center">7 (23.3)</td>
                    <td align="center">0</td>
                    <td align="center">13 (22)</td>
                    <td align="center">0.51</td>
                  </tr>
                  <tr>
                    <td>Post cerebrovascular event</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">1 (12.5)</td>
                    <td align="center">1 (8.3)</td>
                    <td align="center">9 (30)</td>
                    <td align="center">0</td>
                    <td align="center">12 (20)</td>
                    <td align="center">0.31</td>
                  </tr>
                  <tr>
                    <td>Preoperative for cardiac surgery</td>
                    <td align="center">0 (0)</td>
                    <td align="center">0(0)</td>
                    <td align="center">1 (8.3)</td>
                    <td align="center">2 (6.7)</td>
                    <td align="center">0</td>
                    <td align="center">3 (5)</td>
                    <td align="center">0.72</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1001">
                  <p>
                    <italic>Data expressed as an absolute number (n) and percentage (%) for categorical variables as well as the median and interquartile range (median 25-75%) for continuous variables. The comparison between groups was analyzed by X<sup><italic>2</italic></sup> of Pearson (p&lt; 0.05). IQR: interquartile range; No: number; *: Low, moderate, and high-risk patient as established in the Brazilian guideline<sup><italic>26</italic></sup> ; CRP: Cardiac Rehabilitation Program; CVD: Cardiovascular Disease; ICD: Implanted Cardioverter-defibrillator; POAD: Peripheral Obstructive Arterial Disease; VAD: Ventricular Assist Device; p-value: Pearson&#8217;s chi-squared test.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </p>
          <p>Most participants (n=44, 74%) lived in four Brazilian states, which had the highest national human development index (HDI) (above 0.731), according to the literature.<sup><xref ref-type="bibr" rid="B21">21</xref></sup> Considering Brazil&#8217;s average COVID-19 infection rates for the examined period (28.3 per 100,000 inhabitants), three of these four states were above the calculated number ( <xref ref-type="fig" rid="f01001">Figure 1</xref> ). According to data available in the literature,<sup><xref ref-type="bibr" rid="B21">21</xref></sup> the NO region had the second worst HDI in Brazil (0.667) and was the only region where there was no respondent to the questionnaire. Conversely, the SE region had the highest HDI in the country (0.766),<sup><xref ref-type="bibr" rid="B21">21</xref></sup> the highest concentration of CRPs (30/59), the oldest program in Brazil (238 months), highest rate of patients treated per program (78%), and the largest number of patients covered by the public healthcare system (70%).</p>
          <p>
            <fig id="f01001">
              <label>Figure 1</label>
              <caption>
                <title>&#8211; Number of cardiovascular rehabilitation programs and Covid-19 infection rate before and after the first COVID-19 wave (April 20 to 30, 2020) and Human Development Index (HDI) according to federative units and regions of Brazil.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-120-03-e20220135-20135-gf01-en.tif"/></fig>
          </p>
          <p>According to the number of hospitalizations for cardiovascular diseases in Brazil in March 2020 (n=91,231) and the availability of programs for patients after acute cardiovascular events (n=1,817), only 1.99% of patients could be treated in Brazilian cardiovascular rehabilitation programs. The worst scenario occurred in the SO region (number of program/number of patients: 230/20,395: 1.12%), followed by the SE region (810/39,573: 2.04%) ( <xref ref-type="table" rid="t1001">Table 1</xref> ).</p>
          <p>As for clinical characteristics, heart failure (HF) was the most described cardiovascular clinical condition by CRPs&#8217; coordinators (n=55, 93.2%), followed by coronary revascularization (n=53, 89.8%) and patients with a pacemaker or implantable cardioverter-defibrillator (n=44, 74.5%) ( <xref ref-type="table" rid="t1001">Table 1</xref> ). However, the percentage of programs directed at HF patients differed according to Brazil&#8217;s geographic regions. While 100% of the CRPs in the NE and in the SE directed at HF patients, only 89% and 75% of the programs in the MW and in the SO, respectively, directed at this type of patients (p=0.02) ( <xref ref-type="table" rid="t1001">Table 1</xref> ). None of the programs in the MW region directed towards post-heart transplant (post-TX) patients and/or ventricular support users; on the other hand, 43.3% of the CRPs in the SE region attended post-Tx patients (p=0.02) ( <xref ref-type="table" rid="t1001">Table 1</xref> ).</p>
          <p>We found significant discrepancies regarding the core components employed by CRPs among the regions. Nutritional counseling was offered in one program (11%) in the MW region, and in 19 programs (63.3 %) in the SE region (p=0.005) ( <xref ref-type="table" rid="t2001">Table 2</xref> ). Vocational counseling was the least frequently offered component in Brazil (n=1, 8.3%), while exercise (n=59, 100%) and physical activity (n=57, 96%) counseling were the most frequent ones ( <xref ref-type="table" rid="t2001">Table 2</xref> ).</p>
          <p>
            <table-wrap id="t2001">
              <label>Table 2</label>
              <caption>
                <title>&#8211; Operational characteristics of cardiovascular rehabilitation programs before the first confirmed case of COVID-19 in Brazil and hospitalizations for cardiovascular diseases by Brazilian region</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" colspan="2" rowspan="3" scope="col">Operational characteristics</th>
                    <th colspan="6" scope="col">Brazilian region</th>
                    <th rowspan="3" scope="col">Total</th>
                    <th rowspan="3" scope="col">p</th>
                  </tr>
                  <tr>
                    <th colspan="6" scope="col">
                      <hr/>
                    </th>
                  </tr>
                  <tr>
                    <th scope="col">Midwest</th>
                    <th scope="col">Northeast</th>
                    <th colspan="2" rowspan="1" scope="col">South</th>
                    <th scope="col">Southeast</th>
                    <th scope="col">North</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="8">Number (%) of programs that offered specific core components</td>
                    <td align="left">Exercises</td>
                    <td align="center">9 (100)</td>
                    <td align="center">8 (100)</td>
                    <td align="center" colspan="2">30 (100)</td>
                    <td align="center">12 (100)</td>
                    <td align="center">0</td>
                    <td align="center">59 (100)</td>
                    <td align="center">1</td>
                  </tr>
                  <tr>
                    <td align="left">Nutritional counseling</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">6 (75)</td>
                    <td align="center" colspan="2">10 (83.3)</td>
                    <td align="center">19 (63.3)</td>
                    <td align="center">0</td>
                    <td align="center">36 (61)</td>
                    <td align="center">0.005</td>
                  </tr>
                  <tr>
                    <td align="left">Control of risk factors</td>
                    <td align="center">7 (77.8)</td>
                    <td align="center">7 (87.5)</td>
                    <td align="center" colspan="2">9 (75)</td>
                    <td align="center">26 (86.7)</td>
                    <td align="center">0</td>
                    <td align="center">49 (83)</td>
                    <td align="center">0.07</td>
                  </tr>
                  <tr>
                    <td align="left">Quitting tobacco use</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">2 (25)</td>
                    <td align="center" colspan="2">3 (25)</td>
                    <td align="center">9 (30)</td>
                    <td align="center">0</td>
                    <td align="center">15 (25)</td>
                    <td align="center">0.72</td>
                  </tr>
                  <tr>
                    <td align="left">Psychological support</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">3 (37.5)</td>
                    <td align="center" colspan="2">5 (41.7)</td>
                    <td align="center">12 (40)</td>
                    <td align="center">0</td>
                    <td align="center">21(35)</td>
                    <td align="center">0.42</td>
                  </tr>
                  <tr>
                    <td align="left">Counseling on physical activity</td>
                    <td align="center">8 (88.9)</td>
                    <td align="center">8 (100)</td>
                    <td align="center" colspan="2">11(91.7)</td>
                    <td align="center">30 (100)</td>
                    <td align="center">0</td>
                    <td align="center">57 (96)</td>
                    <td align="center">0.27</td>
                  </tr>
                  <tr>
                    <td align="left">Vocational support</td>
                    <td align="center">0 (0)</td>
                    <td align="center">0 (0)</td>
                    <td align="center" colspan="2">1 (8.3)</td>
                    <td align="center">0 (0)</td>
                    <td align="center">0</td>
                    <td align="center">1 (1)</td>
                    <td align="center">0.80</td>
                  </tr>
                  <tr>
                    <td>Treatment adhesion control</td>
                    <td align="center">7 (77.8)</td>
                    <td align="center">7 (87.5)</td>
                    <td align="center" colspan="2">8 (66.7)</td>
                    <td align="center">25 (83.3)</td>
                    <td align="center">0</td>
                    <td align="center">47 (79)</td>
                    <td align="center">0.61</td>
                  </tr>
                  <tr>
                    <td rowspan="9">Assessment methods used by the programs <italic>n (%)</italic></td>
                    <td>Cardiopulmonary exercise test</td>
                    <td align="center">4 (44.4)</td>
                    <td align="center">7 (87.5)</td>
                    <td align="center" colspan="2">6 (50)</td>
                    <td align="center">20 (66.7)</td>
                    <td align="center">0</td>
                    <td align="center">37 (62)</td>
                    <td align="center">0.22</td>
                  </tr>
                  <tr>
                    <td>6-Minute walk test</td>
                    <td align="center">7 (77.8)</td>
                    <td align="center">4 (50)</td>
                    <td align="center" colspan="2">11(91.7)</td>
                    <td align="center">17 (56.7)</td>
                    <td align="center">0</td>
                    <td align="center">39 (66)</td>
                    <td align="center">0.10</td>
                  </tr>
                  <tr>
                    <td>Sit-to-Stand test</td>
                    <td align="center">3 (33.3)</td>
                    <td align="center">4 (50)</td>
                    <td align="center" colspan="2">7 (58.3)</td>
                    <td align="center">12 (40)</td>
                    <td align="center">0</td>
                    <td align="center">26 (44)</td>
                    <td align="center">0.36</td>
                  </tr>
                  <tr>
                    <td>Handgrip strength test</td>
                    <td align="center">2 (22.2)</td>
                    <td align="center">3 (37.5)</td>
                    <td align="center" colspan="2">6 (50)</td>
                    <td align="center">9 (30)</td>
                    <td align="center">0</td>
                    <td align="center">20 (33)</td>
                    <td align="center">0.53</td>
                  </tr>
                  <tr>
                    <td>Respiratory muscle strength</td>
                    <td align="center">4 (44.4)</td>
                    <td align="center">6 (75)</td>
                    <td align="center" colspan="2">7 (58.3)</td>
                    <td align="center">17 (56.7)</td>
                    <td align="center">0</td>
                    <td align="center">34 (57)</td>
                    <td align="center">0.65</td>
                  </tr>
                  <tr>
                    <td>Flexibility test</td>
                    <td align="center">3 (33.3)</td>
                    <td align="center">3 (37.5)</td>
                    <td align="center" colspan="2">4 (33.3)</td>
                    <td align="center">14 (46.7)</td>
                    <td align="center">0</td>
                    <td align="center">24 (40)</td>
                    <td align="center">0.81</td>
                  </tr>
                  <tr>
                    <td>Functional mobility &#8211; Timed up and go test</td>
                    <td align="center">2 (22.2)</td>
                    <td align="center">1(12.52)</td>
                    <td align="center" colspan="2">4 (33.3)</td>
                    <td align="center">8 (26.7)</td>
                    <td align="center">0</td>
                    <td align="center">15 (25)</td>
                    <td align="center">0.75</td>
                  </tr>
                  <tr>
                    <td>Balance evaluation &#8211; Berg's Test</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">2 (25)</td>
                    <td align="center" colspan="2">1 (8.3)</td>
                    <td align="center">9 (30)</td>
                    <td align="center">0</td>
                    <td align="center">13 (22)</td>
                    <td align="center">0.37</td>
                  </tr>
                  <tr>
                    <td>Quality of life test</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">2 (25)</td>
                    <td align="center" colspan="2">1 (8.3)</td>
                    <td align="center">2 (6.7)</td>
                    <td align="center">0</td>
                    <td align="center">6 (10)</td>
                    <td align="center">0.49</td>
                  </tr>
                  <tr>
                    <td rowspan="7">Types of Training offered by the programs <italic>n (%)</italic></td>
                    <td>Motor coordination training</td>
                    <td align="center">4 (44.4)</td>
                    <td align="center">5 (62.5)</td>
                    <td align="center" colspan="2">6 (50)</td>
                    <td align="center">25 (83.3)</td>
                    <td align="center">0</td>
                    <td align="center">40 (68)</td>
                    <td align="center">0.06</td>
                  </tr>
                  <tr>
                    <td>Balance training</td>
                    <td align="center">5 (55.6)</td>
                    <td align="center">6 (75)</td>
                    <td align="center" colspan="2">8 (66.7)</td>
                    <td align="center">27 (90)</td>
                    <td align="center">0</td>
                    <td align="center">46 (78)</td>
                    <td align="center">0.10</td>
                  </tr>
                  <tr>
                    <td>Stretching</td>
                    <td align="center">8 (88.9)</td>
                    <td align="center">8 (100)</td>
                    <td align="center" colspan="2">12 (100)</td>
                    <td align="center">30 (100)</td>
                    <td align="center">0</td>
                    <td align="center">58 (98)</td>
                    <td align="center">0.13</td>
                  </tr>
                  <tr>
                    <td>Moderate-intensity respiratory muscle training</td>
                    <td align="center">2 (22.2)</td>
                    <td align="center">6 (75)</td>
                    <td align="center" colspan="2">6 (50)</td>
                    <td align="center">17 (56.7)</td>
                    <td align="center">0</td>
                    <td align="center">31 (53)</td>
                    <td align="center">0.16</td>
                  </tr>
                  <tr>
                    <td>Moderate-intensity resistance training</td>
                    <td align="center">7 (77.8)</td>
                    <td align="center">7 (87.5)</td>
                    <td align="center" colspan="2">11 (91.7)</td>
                    <td align="center">28 (93.3)</td>
                    <td align="center">0</td>
                    <td align="center">53 (90)</td>
                    <td align="center">0.58</td>
                  </tr>
                  <tr>
                    <td>High-intensity interval training</td>
                    <td align="center">5 (55.6)</td>
                    <td align="center">6 (75)</td>
                    <td align="center" colspan="2">4 (33.3)</td>
                    <td align="center">17 (56.7)</td>
                    <td align="center">0</td>
                    <td align="center">32 (54)</td>
                    <td align="center">0.31</td>
                  </tr>
                  <tr>
                    <td>Moderate-intensity continuous training</td>
                    <td align="center">8 (88.9)</td>
                    <td align="center">8 (100)</td>
                    <td align="center" colspan="2">11 (91.7)</td>
                    <td align="center">30 (100)</td>
                    <td align="center">0</td>
                    <td align="center">57 (97)</td>
                    <td align="center">0.27</td>
                  </tr>
                  <tr>
                    <td rowspan="6">Strategies used to offer remote cardiac rehabilitation <italic>n (%)</italic></td>
                    <td>Phone calls</td>
                    <td align="center">2 (22.2)</td>
                    <td align="center">3 (37.5)</td>
                    <td align="center" colspan="2">4 (33.3)</td>
                    <td align="center">11 (36.7)</td>
                    <td align="center">0</td>
                    <td align="center">20 (33)</td>
                    <td align="center">0.87</td>
                  </tr>
                  <tr>
                    <td>App or software for CRP</td>
                    <td align="center">0 (0)</td>
                    <td align="center">0 (0)</td>
                    <td align="center" colspan="2">0 (0)</td>
                    <td align="center">0 (0)</td>
                    <td align="center">0</td>
                    <td align="center">0 (0)</td>
                    <td align="center">1.00</td>
                  </tr>
                  <tr>
                    <td>Media support (videos and photos)</td>
                    <td align="center">0 (0)</td>
                    <td align="center">1 (12.5)</td>
                    <td align="center" colspan="2">2 (16.7)</td>
                    <td align="center">5 (16.7)</td>
                    <td align="center">0</td>
                    <td align="center">8 (13)</td>
                    <td align="center">0.62</td>
                  </tr>
                  <tr>
                    <td>Promotional material</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">1 (12.5)</td>
                    <td align="center" colspan="2">2 (16.7)</td>
                    <td align="center">11 (36.7)</td>
                    <td align="center">0</td>
                    <td align="center">16 (27)</td>
                    <td align="center">0.24</td>
                  </tr>
                  <tr>
                    <td>Video calls</td>
                    <td align="center">0 (0)</td>
                    <td align="center">1 (12.5)</td>
                    <td align="center" colspan="2">2 (16.7)</td>
                    <td align="center">4 (13.3)</td>
                    <td align="center">0</td>
                    <td align="center">7 (11)</td>
                    <td align="center">0.67</td>
                  </tr>
                  <tr>
                    <td>Others</td>
                    <td align="center">1 (11.1)</td>
                    <td align="center">1 (12.5)</td>
                    <td align="center" colspan="2">1 (8.3)</td>
                    <td align="center">4 (13.3)</td>
                    <td align="center">0</td>
                    <td align="center">7 (11)</td>
                    <td align="center">0.97</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN2001">
                  <p>
                    <italic>Data expressed as an absolute number (n) and percentage (%) for categorical variables. Comparisons between groups were analyzed by Kruskal-Wallis (p&lt;0.05); CRP: cardiac rehabilitation program; p-value: Kruskal-Wallis test.</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </p>
          <p>The main exercise modalities offered by CRPs for in-person sessions were stretching (98%), moderate continuous aerobic training (97%), and moderate-intensity resistance training (90%) ( <xref ref-type="table" rid="t2001">Table 2</xref> ). None of the 59 programs used specific CR software or applications before the COVID-19 pandemic; telephone calls (n=20, 33%) and promotional materials (n=16, 27%) were the most prevalent remote initiatives before the pandemic period ( <xref ref-type="table" rid="t2001">Table 2</xref> ).</p>
        </sec>
        <sec>
          <title>Impact of COVID-19 on Brazil&#8217;s cardiovascular rehabilitation programs</title>
          <p>According to the national average of COVID-19 infection, Brazilian states were differently affected in April 2020 (28.3 per 100,000 inhabitants). In the SE region, 23 (63.9%) of the CRPs were in cities with an infection rate above the national average, while 5.6% of the CRPs in the SO, 19.4% in MW, and 11. 1% in NE were conducted in cities with an infection rate above the national average (p=0.002) ( <xref ref-type="table" rid="t3001">Table 3</xref> ).</p>
          <p>
            <table-wrap id="t3001">
              <label>Table 3</label>
              <caption>
                <title>&#8211; Place of cardiovascular rehabilitation program according to the national average rate of COVID-19 (&gt; or &#8804;28.3 per 100,000 inhabitants) per Brazilian region and the main impacts of the programs in the first 60 days after the first case of COVID-19 in Brazil</title>
              </caption>
              <table frame="hsides" rules="groups">
                <colgroup>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" rowspan="5" scope="col">Regions of Brazil/Impacts of the pandemic</th>
                    <th colspan="6" scope="col">National average rate of COVID-19 calculated in the 60 days of pandemic</th>
                    <th align="left" colspan="2" rowspan="4" scope="col" style="font-weight:normal"> </th>
                    <th rowspan="5" scope="col">Pearson&#8217;s chi-square test</th>
                  </tr>
                  <tr>
                    <th colspan="6" scope="col">
                      <hr/>
                    </th>
                  </tr>
                  <tr>
                    <th colspan="4" rowspan="1" scope="col">&lt; = 28.3 per 100,000 inhabitants</th>
                    <th colspan="2" rowspan="1" scope="col">&gt; 28.3 per 100,000 inhabitants</th>
                  </tr>
                  <tr>
                    <th colspan="6" rowspan="1" scope="col">
                      <hr/>
                    </th>
                  </tr>
                  <tr>
                    <th scope="col">n</th>
                    <th colspan="3" rowspan="1" scope="col">%</th>
                    <th scope="col">n</th>
                    <th scope="col">%</th>
                    <th align="left" scope="col" style="font-weight:normal">Total (n)</th>
                    <th align="left" scope="col" style="font-weight:normal">Total (%)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left">Midwest</td>
                    <td align="center">2</td>
                    <td align="center" colspan="3">8.7</td>
                    <td align="center">7</td>
                    <td align="center">19.4</td>
                    <td align="center">9</td>
                    <td align="center">15.2</td>
                    <td rowspan="4">p = 0.002</td>
                  </tr>
                  <tr>
                    <td align="left">Northeast</td>
                    <td align="center">4</td>
                    <td align="center" colspan="3">17.4</td>
                    <td align="center">4</td>
                    <td align="center">11.1</td>
                    <td align="center">8</td>
                    <td align="center">13.6</td>
                  </tr>
                  <tr>
                    <td align="left">Southeast</td>
                    <td align="center">7</td>
                    <td align="center" colspan="3">30.4</td>
                    <td align="center">23</td>
                    <td align="center">63.9</td>
                    <td align="center">30</td>
                    <td align="center">50.9</td>
                  </tr>
                  <tr>
                    <td align="left">South</td>
                    <td align="center">10</td>
                    <td align="center" colspan="3">43.5</td>
                    <td align="center">2</td>
                    <td align="center">5.6</td>
                    <td align="center">12</td>
                    <td align="center">20.3</td>
                  </tr>
                  <tr>
                    <td align="left">
                      <italic>Total</italic>
                    </td>
                    <td align="center">
                      <italic>23</italic>
                    </td>
                    <td align="center" colspan="3">
                      <italic>100</italic>
                    </td>
                    <td align="center">
                      <italic>36</italic>
                    </td>
                    <td align="center">
                      <italic>100</italic>
                    </td>
                    <td align="center">59</td>
                    <td align="center">100</td>
                    <td align="left"> </td>
                  </tr>
                  <tr>
                    <td align="left">Closing of the program</td>
                    <td align="center">2</td>
                    <td align="center" colspan="3">8.7</td>
                    <td align="center">1</td>
                    <td align="center">2.8</td>
                    <td align="center">3</td>
                    <td align="center">5</td>
                    <td rowspan="5">p = 0.09</td>
                  </tr>
                  <tr>
                    <td>Interruption of the program</td>
                    <td align="center">15</td>
                    <td align="center" colspan="3">65.2</td>
                    <td align="center">30</td>
                    <td align="center">83.3</td>
                    <td align="center">45</td>
                    <td align="center">76.3</td>
                  </tr>
                  <tr>
                    <td>Reduction in the number of sessions</td>
                    <td align="center">6</td>
                    <td align="center" colspan="3">26.1</td>
                    <td align="center">2</td>
                    <td align="center">5.6</td>
                    <td align="center">8</td>
                    <td align="center">13.6</td>
                  </tr>
                  <tr>
                    <td>Normal functioning of the program</td>
                    <td align="center">0</td>
                    <td align="center" colspan="3">0</td>
                    <td align="center">1</td>
                    <td align="center">2.8</td>
                    <td align="center">1</td>
                    <td align="center">1.7</td>
                  </tr>
                  <tr>
                    <td>Others</td>
                    <td align="center">0</td>
                    <td align="center" colspan="3">0</td>
                    <td align="center">2</td>
                    <td align="center">5.5</td>
                    <td align="center">2</td>
                    <td align="center">3.4</td>
                  </tr>
                  <tr>
                    <td>
                      <bold>
                        <italic>Total</italic>
                      </bold>
                    </td>
                    <td align="center">
                      <italic>23</italic>
                    </td>
                    <td align="center" colspan="3">
                      <italic>100</italic>
                    </td>
                    <td align="center">
                      <italic>36</italic>
                    </td>
                    <td align="center">
                      <italic>100</italic>
                    </td>
                    <td align="center">59</td>
                    <td align="center">100</td>
                    <td> </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN3001">
                  <p>
                    <italic>Categorical variables expressed as absolute number (n) and percentage (%). The comparison between groups was analyzed by Pearson&#8217;s chi-square test (p&lt; 0.05).</italic>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </p>
          <p>The greatest impact of the COVID-19 pandemic on CRPs was the city-wide commercial restrictions, which occurred regardless of the local infection rate, as 30 of 36 (83.3%) programs were in cities with a rate above the average, and 15 of 23 (65.2%) programs were in cities with a rate below the average ( <xref ref-type="table" rid="t3001">Table 3</xref> ).</p>
          <p>A reduction in the number of CR sessions offered was the second greatest impact, observed in 26.1% of the cities with the highest COVID-19 infection rates (26.1%) and in 5.6% in the cities with the lowest COVID-19 infection rates (p=0.097) ( <xref ref-type="table" rid="t3001">Table 3</xref> ).</p>
          <p>The main adaptations made by the programs that continued to offer CR sessions during the pandemic were: 1) offer or remote services (n=18, 31%), 2) changes in the duties of health professionals (n=11, 19%), 3) reducing working hours of health professionals (n=10, 17%) and 4) reducing the number of sessions (n=9, 15%) ( <xref ref-type="fig" rid="f02001">Figure 2</xref> ). The most used strategies to facilitate remote sessions during the COVID-19 pandemic were videos and photos (expanded from three to 17 programs, p=0.007) and video calls (expanded from three to 12 programs, p = 0.017) ( <xref ref-type="fig" rid="f03001">Figure 3</xref> ).</p>
          <p>
            <fig id="f02001">
              <label>Figure 2</label>
              <caption>
                <title>&#8211; Most frequent observed and expected changes in cardiac rehabilitation programs (CRP) imposed by the COVID-19 pandemic and CRP professionals&#8217; perceptions about managing COVID-19 patients during the first pandemic wave (April 20 to 30, 2020) in Brazil.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-120-03-e20220135-20135-gf02-en.tif"/></fig>
          </p>
          <p>
            <fig id="f03001">
              <label>Figure 3</label>
              <caption>
                <title>&#8211; Strategies used to offer remote cardiac rehabilitation programs during the first wave of COVID-19 (April 20 to 30, 2020) in Brazil; McNemar test was used for statistical analysis, p&lt;0.05.</title>
              </caption>
              <graphic xlink:href="1678-4170-abc-120-03-e20220135-20135-gf03-en.tif"/></fig>
          </p>
          <p>Only 17 CRPs&#8217; coordinators (28.81%) reported that health professionals felt prepared to provide CR in the face of new restrictions during the pandemic period, and only three CRPs (5.08%) admitted patients to CR ( <xref ref-type="fig" rid="f02001">Figure 2</xref> ).</p>
          <p>Most participants (93.22%) responded that having an official statement on CR, issued by Brazilian scientific associations during the pandemic COVID-19, was important in getting a direction or orientation during this unprecedented time. Additionally, 74.57% of respondents also reported a need for training and qualification in managing CRPs, and 72.88% sought online applications on remote CR ( <xref ref-type="fig" rid="f02001">Figure 2</xref> ).</p>
        </sec>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>This study provides information regarding the impact of COVID-19 in the first 60 days of pandemic (April 2020), highlighting the large reduction in the number of programs available during this critical period. We also identified the main strategies of CRPs to promote physical activity throughout the pandemic. Secondly, we presented an update on the demographic, clinical, and operational characteristics of CRPs in Brazil, showing the differences among services by region and reaffirming the need for CR services in Brazil.</p>
        <sec>
          <title>Cardiovascular rehabilitation programs before the COVID-19 pandemic</title>
          <p>Of the estimated 75 CRPs in Brazil, we obtained updated information on demographic and clinical characteristics prior to the COVID-19 pandemic from 17 programs and the impact of 59 programs, which is the largest number of CRPs assessed by survey in Brazil.</p>
          <p>As experienced by Britto et al.,<sup><xref ref-type="bibr" rid="B17">17</xref></sup> we did not have any respondents from the NO region, preventing us from characterizing the CRPs of this region. In the month prior to the survey (March 2020), there were 4,358 hospital admissions related to cardiovascular diseases in the NO region,<sup><xref ref-type="bibr" rid="B18">18</xref></sup> which further reinforces a possible precarious situation in this region.</p>
          <p>Considering the number of patients hospitalized for cardiovascular diseases in all Brazilian regions in the same period, and the mean duration of 36 sessions for each CR patient, we found extremely low participation rates, ranging from only 1.12% in the SO region to 3.24 % in the MW region. These numbers do not include the previous demand for CRPs from non-hospitalized participants with cardiovascular diseases, which we assume to be even higher since the rate of hospitalization for these conditions is estimated at 11.2%, according to a recent systematic review.<sup><xref ref-type="bibr" rid="B22">22</xref></sup> The great demand for CRPs combined with the low number of CRPs available makes it clear there is a considerable need for investments in this area.</p>
          <p>Regarding cardiovascular diseases, HF was the most frequently reported condition. However, some diseases may be less frequently mentioned in CRPs due to their high complexity, such as post-transplant. In the MW region, for example, post-transplant patients are probably not referred to CRPs, and the lack of care for these patients in this region may also be related to the low number of public health services available. Another possibility is that not all programs in the MW region have answered the online survey. In any case, public policies to increase patient referral and expand the number of CRPs in the MW region are of extreme priority.</p>
          <p>As for the operational characteristics of CRPs, our study identified that the only core component present in 100% of CRPs was exercise, which was similar to other studies.<sup><xref ref-type="bibr" rid="B23">23</xref></sup> This is a disturbing finding since CRPs are expected to offer all eight core components: 1) physical exercise, 2) nutritional counseling, 3) risk factor control, 4) smoking cessation, 5) psychological support, 6) physical exercise counseling, 7) vocational support and 8) treatment adherence and control.<sup><xref ref-type="bibr" rid="B11">11</xref></sup> A previous study in Canada demonstrated that nutritional counseling and guidance in physical activity are provided in all CRPs.<sup><xref ref-type="bibr" rid="B24">24</xref></sup> Additional public and private initiatives focused on the national coverage of services and professional training seem necessary to deliver all the required core components and thus optimize the care of patients with cardiovascular disease in Brazil.</p>
        </sec>
        <sec>
          <title>Impacts of COVID-19 on cardiovascular rehabilitation programs</title>
          <p>The first strategy described to keep participants in CRPs was the introduction of remote activities, mostly video calls (33%), followed by photos and videos (27%). A previous study showed favorable results for exercise prescription, adherence to rehabilitation, and behavioral changes through the usage of images and videos.<sup><xref ref-type="bibr" rid="B25">25</xref></sup> Other studies also indicated remote rehabilitation as an important strategy to increase the availability of CR for patients with coronary disease.<sup><xref ref-type="bibr" rid="B26">26</xref></sup> We hope that these resources will continue to be incorporated even after the pandemic, as increasing CR adherence and coverage, as well as delivering more core components for a greater number of patients is highly recommended in the literature.<sup><xref ref-type="bibr" rid="B27">27</xref> - <xref ref-type="bibr" rid="B29">29</xref></sup></p>
          <p>Remote activities have been offered by different approaches. Those that use digital platforms (applications or software) and include prescription and real-time monitoring capabilities appear to be more effective in increasing patient adherence and involvement in CRPs.<sup><xref ref-type="bibr" rid="B30">30</xref></sup> In our study, only two CRPs used digital platforms during the COVID-19 pandemic, reinforcing the urgent need to improve investments and knowledge in this field while increasing the availability of resources for patients in Brazil and probably in many other nations.</p>
          <p>Regarding the impact of the COVID-19 pandemic on CRP professionals, we found that most of them felt unprepared for the challenges presented by COVID-19 restrictions and insecure in providing CR during the pandemic. Health professionals often reported fear of becoming infected or infecting their families and reported emotional distress due to changes in protocols and the use of protective equipment.<sup><xref ref-type="bibr" rid="B31">31</xref></sup> It is therefore clear that the COVID-19 pandemic also negatively impacted health professionals&#8217; routines, likely interfering with the delivery, management, and availability of CRPs.</p>
        </sec>
        <sec>
          <title>Limitations</title>
          <p>This study had some limitations, including the fact that not all CRPs in Brazil may have received the survey and all the questions must have been answered to include the survey in the study; that one or more questions on the online survey may have been misinterpreted, and that calculation of the COVID-19 infection rate may have been underestimated.</p>
          <p>In addition, the cross-sectional nature of this study precludes any causal inference. Furthermore, although we had the support of several scientific associations in Brazil to ensure the ideal distribution of the online survey, considering the non-probabilistic sampling method utilized, it is possible that not all CRPs in Brazil received the survey via the internet, and consequently were underrepresented. However, our study had the largest sample size of CRPs in Brazil, providing important data from before and after the COVID-19 pandemic that help guide CRPs in the future. However, a national, multidisciplinary registry is needed to facilitate communication and share experiences among CRPs across the country.</p>
          <p>Interpretation of Internet-based studies can be challenging. Although the questions had been developed and carefully tested by professionals with extensive experience in the field of CR and CRP management, one or more of the survey questions may have been misinterpreted.</p>
          <p>The respondents were required to answer every question to be able to continue to subsequent sections of the online survey; otherwise, it was not possible to access the entire form. Also, the respondent could take the time necessary to answer each question, as our form did not require a minimum or maximum time for that.</p>
          <p>Finally, regarding the possible underestimation of COVID-19 infection rates, the lack of supplies at the beginning of the pandemic in Brazil may have contributed to a lower notification of cases, especially in low-income regions. However, we used data from official Brazilian entities, and this condition occurred in other parts of the world at the beginning of the pandemic.</p>
        </sec>
      </sec>
      <sec sec-type="conclusions">
        <title>Conclusion</title>
        <p>Despite the substantial need for CRPs in Brazil, the number of programs remains significantly low in view of national and local demand. The COVID-19 pandemic had an unfavorable effect on CRPs by decreasing the number of CR sessions available nationwide despite encouraging telerehabilitation activities during the first two months of the COVID-19 pandemic. A substantial percentage of health professionals in CRPs did not consider it safe to perform CR with COVID-19 patients and were not prepared to supervise the programs on-site. National and multicenter studies analyzing CRPs at different stages of the COVID-19 pandemic are needed to assess their impacts and share successful strategies for mitigating the negative impacts of the pandemic on these programs worldwide.</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn fn-type="other">
          <p>Study association</p>
          <p>This article is part of the thesis of master submitted by Iara Sousa Cez&#225;rio Jardim, from Universidade de Bras&#237;lia.</p>
        </fn>
      </fn-group>
      <fn-group>
        <fn fn-type="supported-by">
          <p>Sources of funding: There were no external funding sources for this study.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
